Effekt av gradert sykmelding vs full sykmelding...2 Content Published by Norwegian title...

78
2018 SYSTEMATIC MAPPING REVIEW: Effects of partial sick leave versus full- time sick leave on sickness absence and work participation REPORT

Transcript of Effekt av gradert sykmelding vs full sykmelding...2 Content Published by Norwegian title...

  • 2018SYSTEMATIC MAPPING REVIEW:

    Effects of partial sick leave versus full-time sick leave on sickness absence and work participation

    REPORT

  • 2 Content

    Publishedby

    Norwegiantitle

    FolkehelseinstituttetOmrådeforhelsetjenesterEffektavgradertsykmeldingvs.fullsykmeldingpåsykefraværogarbeidstilknytning:ensystematiskkartleggingsoversikt

    Englishtitle Effectsofpartialsickleaveversusfull‐timesickleaveonsicknessabsenceandworkpar‐ticipation:asystematicmappingreview

    Responsible CamillaStoltenberg,directorAuthors

    JoseF.Meneses‐Echavez,projectleader,researcherNikita,Baiju,researcherRigmorC.Berg,departmentdirector

    ISBN 978‐82‐8082‐917‐7Typeofreport SystematicmappingreviewNo.ofpages 56(77inklusivvedlegg)Comissioner NAV

    Subjectheading(MeSH)

    Sickleave,returntowork,disabilityevaluation

    Citation

    Meneses‐EchavezJF,BaijuN,BergRC.Effectsofpartialsickleaveversusfull‐timesickleaveonsicknessabsenceandworkparticipation:asystematicmappingreview.Report−2018.Oslo:Folkehelseinstituttet,2018.

  • 3 Content

    Content

    CONTENT 3

    HOVEDBUDSKAP 5

    SAMMENDRAG 6

    KEYMESSAGES 9

    EXECUTIVESUMMARY(ENGLISH) 10

    PREFACE 13

    ABBREVIATIONS 14

    BACKGROUND 15

    METHODS 21 Whatisasystematicmappingreview? 21 Selectioncriteria(identifyingtheresearchquestion) 22 Literaturesearch(identifyingrelevantstudies) 23 Studyselection 24 Dataextraction(chartingthedata) 24 Qualityappraisaloftheincludedstudies 24 Collatingandsummarizingtheresults 25 RESULTS 26 Searchresults 26 Descriptionofincludedstudies 27 Qualityappraisaloftheincludedstudies 35 Summaryofmainfindingsfromtheincludedstudies 35 DISCUSSION 45 Mainfindings 45 Generalizabilityandstrengthoffindings 46 Comparisonwithotherreviews 48 Strengthsandweaknesses 48 Implicationsforpractice 49 CONCLUSION 50

    REFERENCES 51

  • 4 Content

    APPENDIX 57 Appendix1.Glossary 57 Appendix2.Searchstrategies 58 Appendix3.Excludedstudies 61 Appendix4.Adjustedanalysesandcovariatesintheregistry‐basedstudies 62 Appendix5.Definitionofthestatisticalanalysesintheregistry‐basedstudies 73 Appendix6.Qualityappraisaloftherandomizedcontrolledtrial 75 Appendix7.Qualityappraisaloftheregistry‐basedstudies 76

  • 5 Hovedbudskap

    Hovedbudskap

    Høytsykefraværblantarbeidstakereerenbekymringimangeland.Gra‐dertsykmeldingerenkombinasjonavarbeidogsykepengersombenyt‐tesnårarbeidstakerenerdelvisarbeidsufør,slikatdenansattekanværefraværendefrajobbendelavtidenogjobbeendelavtiden.Folkehelse‐instituttetfikkioppdragavNAVåutføreenkartleggingavdenempiriskeforskningenomeffektenavgradertsykmeldingversusfullsykmelding.MetodeViutførteensystematiskkartleggingsoversikt.Ijanuar2018gjordevietomfattendelitteratursøk,inkludertsøkistoredatabaser,referanselister,grålitteratur,ogvikontaktetarbeidslivsorganisasjonerogdepartement.Toforskerevurderteuavhengigavhverandrealleidentifisertereferan‐serogdenmetodiskkvalitetentildeinkludertestudiene.Vihentetutdatafradeinkludertestudieneogutførtebeskrivendeanalyser.Synteseavindividuellestudieresultaterinngårikkeiensystematiskkartleg‐gingsoversikt.ResultaterViinkluderteenrandomisertkontrollertstudieog12registerbasertestudier.De13studieneinkluderteca.2,74millionersykmeldte.Studienehaddefølgendekjennetegn: Elleveavstudienevarfranordiskeland,inkludertfirefraNorge. Allestudienehaddeentenmoderatellerhøymetodiskkvalitet. Denrandomisertekontrollertestudieninkludertefinskeansatte

    (n=62)somvarsykmeldtpågrunnavmuskel‐ogskjelettplager,mensderegisterbasertestudienehovedsakeliginkluderteansattemedmuskel‐ogskjelettplagerellerpsykiskelidelser.

    Detvar15utfall,hvoravhovedutfallenevararbeidsdeltakelse,varighetavsykefravær,arbeidsførhetogsosialestønader.

    Funnenetyderpåatgradertsykmeldingerforbundetmedflerepositiveutfall,sliksomhøyerearbeidsdeltakelseogkorteresykefravær,mensikrekonklusjoneromeffekteneavgradertsykmeldingerbegrensetpågrunnavdetstoreflertalletavobservasjonsstudierpådettetemaet.

    Tittel: Effekt av gradert sykmelding vs. full sykmelding på sykefravær og arbeidstilknytning: en systematisk kartleggingsoversikt ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Publikasjonstype: Systematisk Kartleggingsoversikt En systematisk karleggingsoversikt kartlegger og kategoriserer eksisterende forskning på et tema og identifiserer forskningshull som kan lede til videre forskning. ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Svarer ikke på alt: - Ingen syntese av resultater - Ingen vurdering av evidensen ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Hvem står bak denne publika-sjonen? Folkehelseinstituttet har gjennomført oppdraget etter forespørsel fra NAV ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Når ble litteratursøket utført? Søk etter studier ble avsluttet januar 2018.

  • 6 Sammendrag

    Sammendrag

    Bakgrunn

    Gittdethøyesykefraværblantarbeidstakereerdetimangelandenprioritetåøkear‐beidsdeltakelsenblantpersoneriarbeidsføralder.Gradertsykmeldingerenkombina‐sjonavarbeidogsykepengersombenyttesnårarbeidstakerenerdelvisarbeidsufør,slikatdenansattekanværefraværendefrajobbendelavtidenogjobbeendelavti‐den.Detforståssometgradertfravær,somgjøratfolkmedredusertarbeidskraftkanjobbedeltidogfortsattbeholdetilknytningentilarbeidsmarkedet.Gradertsykmeldingvarierermellom20%og99%,ogkanmuliggjøreraskerereturtilarbeid.Imangeland,spesieltdenordiskelandene,erdettetiltaketsettsomdetførstealternativetforåtakleøkendesykefraværogforhindreekskluderingfraarbeidsmarkedet.Forskningpågradertsykmeldingharhovedsakeligvistlovenderesultater,spesieltidenordiskelandene.EnnyliguførtevalueringavordningenmedgradertsykmeldingiNorgeidentifiserteimidlertidbarrierernårdetgjelderbrukenavordningen,sliksomomfattendebyråkrati,vanskeligåforstå‐ogtilgjengeligtilgangtilinformasjonsamtmangelpåkvalitetskontroll.Selvomlovenderesultatererpublisertharforskningenomeffektenavgradertsykmeldingblittkritisertavmetodiskegrunner,somforeksem‐pelrisikoforutvalgsskjevhetogsvakhetervedmålingavarbeidsdeltakelse.Peridagfinsdetingensystematiskeanalyseravkunnskapsgrunnlagetforeffekteneavgradertsykmelding.Metode

    Vigjennomførteensystematiskkartleggingsoversiktihenholdtilinternasjonalestan‐darder.Ensystematiskkartleggingsoversikt(ogsåkjentsomsystematicscopingreview)erenkunnskapsoppsummeringsomkartleggerogbeskrivereksisterendelitteratur‐ellerforskningsgrunnlagpåetbestemttema.Oppsummeringeninkludereringensyste‐matisksynteseavindividuellestudieresultater(f.eks.ingenmetaanalyse).Viinkludertestudieruansettspråksomevaluerteeffekteneavgradert‐versusfullsykmeldingpåsy‐kefraværogarbeidsdeltakelse.Relevantestudiedesignvarprospektivekontrollertestudiersamtregisterbasertestudier(RB).Prosjektteamet(forskerne)ogoppdragsgive‐ren(NAV)diskuterteogbleenigeomprosjektplanen.Visøkteiåttestorelitteraturdatabaser(frabegynnelseninntil2018),kontakteteksper‐ter,ogsøktewebsidenetilarbeidslivsorganisasjonerogrelevantedepartement,refe‐ranselistenetilalleinkludertestudieroglitteraturoversikterpåtemaet.Toforskerevurderteuavhengigavhverandredeidentifisertereferanseneogdatauthentingenble

  • 7 Sammendrag

    dobbeltsjekket.Vigjennomførteuavhengigkvalitetsvurderingavdeinkludertestudi‐enemedbrukavvalidertesjekklister.Vigruppertedatahentetfradeinkludertestudi‐eneihenholdtildereshovedkarakteristika,utførtebeskrivendeanalyserogpresent‐erteresultateneitekstogtabeller.Resultat

    Trettenstudier,publisertmellom2010‐2017,møtteinklusjonskriteriene.Allestudienemålteeffekteravgradertsykmeldingsammenlignetmedfullsykmeldingblantvoksnesykmeldte.Viinkluderteenfinskrandomisertkontrollertstudie(RCT)(n=62somvarsykmeldtpågrunnavmuskel‐ogskjelettplager)og12RBer(n=2,742,497somvarsyk‐meldtpågrunnavhovedsakeligmuskel‐ogskjelettplagerellerpsykiskelidelser).Del‐takerneidetolvRBenevarfraNorge,Danmark,Finland,SverigeogTyskland.Detvarulikegraderavgradertsykmeldingistudiene.IdenfinskeRCTenble50%gra‐dertsykmeldinggitttil70%avdesykmeldte,mens30%avdesykmeldtearbeidetkorteretimer3‐4dageriuken.IRBenevar50%denhyppigstbruktegraderingen.RBeneanalysertelandsdekkenderegisterdatapåsykefravær(bådegradert‐ogfullsyk‐melding)mellom2001og2014.MedhensyntilstudienesmetodiskekvalitethaddedeninkluderteRCTenmoderatkvalitet;dethaddeogså11avde12RBenemensenRBhaddehøymetodiskkvalitet.Deterviktigåfremheveatregisterbasertestudiererdår‐ligegnettilåpåvisekausalesammenhenger.SammendragavhovedfunnfradeinkludertestudieneSykefravær:DenfinskeRCTenogtreRBerrapportertepositiveresultateravgradertsykmelding,sammenlignetmedfullsykmelding,påsykefraværvedettårsoppfølging.ArbeidsdeltakelseReturn‐to‐work(RTW):DenfinskeRCTenfantatgradertsykmeldingforbedretar‐beidsdeltakelsensammenlignetmedfullsykmeldingvedettårsoppfølging.AlledeniRBenesommåltearbeidsdeltakelse,bortsettfraennorskRB,vistebedreresultaterblantdemedgradertsykmeldingsammenlignetmedfullsykmelding.Arbeidsledighet:TreRBer–fraNorge,TysklandogFinland–rapportertelaverear‐beidsledighetblantpersonersomhaddeværtpågradertsykmeldingsammenlignetmedpersonersomhaddeværtfulltidssykmeldt.

    GradavuførhetogattføringGjentakendesykefravær:DenfinskeRCTenfantingensignifikanteforskjellermellomgruppensomhaddegradertsykmeldingogdesomhaddefullsykmeldingnårdetgjel‐dergjentakendesykefravær.Funksjonsnivå:Ingenforskjellermellomgradert‐ogfullsykmeldingblerapportertidenfinskeRCTenvedettårsoppfølgingogiénRBfraNorge,menstoandreRBer(fraNorgeogFinland)fantatgradertsykmeldingvarforbundetmedbedringerifunksjons‐nivå.

  • 8 Sammendrag

    Produktivitetstap:KundenfinskeRCTenrapportertepåutfalletproduktivitetstap.DatafradenneRCTenvisteatdetikkevarsignifikantforskjellpåproduktivitetstapmellomgradert‐ogfullsykmeldingvedettårsoppfølging.Uførepensjon:EnnorskRBvisteatgradertsykmeldingvarforbundetmedenhøyeregradavuførepensjonsammenlignetmedfullsykmelding.DetotyskeRBenerappor‐terteenredusertrisikoforåmottauførepensjonhosansattepågradertsykmelding.EnfinskRBfantatgradertsykmeldingvarforbundetmedlavererisikoforfulluførepen‐sjonsammenlignetmedfullsykmelding,mensmotsattsammenhengblefunnetforri‐sikofordelvisuførepensjon.Sosialestønader:FireRBerfantatgradertsykmeldingvarforbundetmedenlaveregradavsosialestønadersammenlignetmedfullsykmelding.HelserelaterteutfallBaretoavdeinkludertestudienerapportertepåhelserelaterteutfall.DenfinskeRCTenfantingenforskjellermellomgradertogfullsykmeldingpåsmerteintensitet,menvistepositiveresultaterforgradertsykmeldingpåbådeselvrapportertgenerellhelseoghel‐serelatertlivskvalitet.EntyskRBvisteatpersonermedgradertsykmeldingfungertebedrefysiskogfølelsesmessigenndesomhaddefullsykmelding.DenfinskeRCTenfantingenforskjellermellomgradertogfullsykmeldingnårdetgjaldtdesykmeldtesdepresjonssymptomer,mensdentyskeRBenvisteatgradertsykmeldingvarforbundetmedforbedringermedhensyntildepresjon‐ogangstsymptomerogarbeidsevne,sam‐menlignetmedfullsykmelding.Konklusjon

    Forskningsgrunnlagetforeffektenavgradertsykmeldingsammenlignetmedfullsyk‐meldingbeståravénRCTog12RBer,medtotaltca2,74millionerpersonersomersyk‐meldtpågrunnavhovedsakeligmuskel‐ogskjelettplagerellermentalelidelser.Deink‐ludertestudienevistesammenfallendemønsteriresultatifavøravgradertsykmelding.BådeRCTenogRBeneindikerteatgradertsykmeldingerforbundetmedkorteresyk‐meldingoghøyerearbeidsdeltakelse.ResultatenefradenfinskeRCTenindikerteatan‐sattemedmuskel‐ogskjelettsykdommerrapportertebedregenerellhelseoglivskvali‐tetmedgradertsykmelding.DenneRCTenfantatgradertsykmeldingikkeharnoenef‐fektpågjentakendesykefravær,produktivitetstapellersmerte.Positivesammen‐hengermellomgradertsykmeldingogforbedringavansattesfunksjonshemmingogdepressivesymptomerblestøttetavRBene,menikkeavRCTen.ResultaterfraRBeneantyderatbrukavgradertsykmeldingerforbundetmedlaveresannsynlighetforåmottabådeuførepensjonogsosialestønader,samtbedreskårepåfysisk‐ogfølelses‐messigfungering,angstogarbeidsevne.SikrekonklusjoneromeffekteneavgradertsykmeldingerbegrensetpågrunnavdetstoreflertalletavRBerpådettetemaet.ObservasjonellestudiersomRBergirenbety‐deligrisikoforsystematiskeskjevheteriresultatenesomgjørdetvanskeligågisikresvarpåspørsmålomårsakogvirkning.FlereRCTeravhøymetodiskkvaliteternød‐vendigforåkunnetrekkeklarekonklusjoner.

  • 9 Keymessages

    Keymessages

    Inmanycountries,thehighsicknessabsencerateinworkingagepeopleisaconcern.Partialsickleave(PTSL)isareturn‐to‐workstrategythatenablesemployeestobeabsentfromworkpartofthetimeandremainworkingforaproportionofthetime.TheNorwegianLaborandWelfareAdministration(NAV)commissionedtheNorwegianInstituteofPublicHealthtomapallevidenceontheeffectsofPTSLversusfull‐timesickleave(FTSL)onsicknessabsenceandworkparticipation.MethodsWeconductedasystematicmappingreview.InJanuary2018,wecon‐ductedanextensiveliteraturesearch,includingsearchesinmajordata‐bases,referencelists,greyliterature,andwecontactedlaboragenciesandinternationalministries.Twoindependentreviewersscreenedallre‐trievedrecordsandappraisedtheincludedstudies.Weextracteddatafromtheincludedstudiesandperformeddescriptiveanalyses.Synthesisofindividualstudyresultsisnotpartofsystematicmappingreviews.ResultsWeincludedonesmallrandomizedcontrolledtrialand12registry‐basedstudies.The13studiesincludedabout2.74millionemployeesonsickleave.Thestudiesexhibitedthefollowingcharacteristics: ElevenofthestudieswerefromNordiccountries,includingfourfrom

    Norway. Allstudieshadeithermoderateorhighmethodologicalquality. TherandomizedcontrolledtrialincludedFinnishemployees(n=62)

    whoweresick‐listedduetomusculoskeletaldisorders,whiletheregistry‐basedstudiesmostlyincludedemployeeswitheithermusculoskeletal‐ormentaldisorders.

    Therewere15outcomes,ofwhichthemostfrequentlyreportedoutcomeswereworkparticipation,sicknessabsenceduration,disability,andsocialwelfarebenefits.

    ThefindingsindicatedthatPTSLmaybeassociatedwithseveralfavora‐bleoutcomessuchasshortersicknessabsenceandhigherworkpartici‐pation.However,firmconclusionsabouttheeffectsofPTSLcannotbedrawnduetotheoverwhelmingmajorityofobservationalstudiesinthisbodyofevidence.

    Title: Effects of partial sick leave ver-sus full-time sick leave on sick-ness absence and work partici-pation: a systematic mapping re-view ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Type of publication: Systematic mapping re-view A systematic mapping review maps out and categorizes exist-ing research on a topic, identify-ing research gaps that can guide future research. ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Doesn’t answer everything: No synthesis of the results No recommendations are made ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Publisher: Norwegian Institute of Public Health ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐Updated: Last search for studies: January 2018.

  • 10 Executive summary (English)

    Executivesummary(English)

    BackgroundInmanycountries,highsicknessabsenceratesmeanthattheneedtoincreaseworkparticipationofworkingagepeopleisacriticalpriority.Partialsickleave(PTSL),alsocalledgradedsickleave,isareturn‐to‐workstrategythatenablesemployeestobeab‐sentfromworkpartofthetimeandremainworkingforaproportionofthetime.Itisunderstoodasagradedleave,whichallowspeoplewithreducedworkabilitytoworkparttimeandstillkeepthelinktothelabormarket.PTSLvariesbetween20%upto99%,andmightfacilitateaprogressivereturntowork.Inmanycountries,especiallytheNordiccountries,thisreturn‐to‐workstrategyhasbeenconsideredthefirstoptiontotackleincreasingsicknessabsenceratesandtopreventlabormarketexclusion.ResearchonPTSLhasshownlargelypromisingresults,especiallyintheNordiccoun‐tries.ArecentevaluationofthePTSLarrangementinNorway,however,highlightedbarrierstoitsuse,suchasbureaucraticredtape,lackofeasytounderstandandaccessinformation,andqualitycontrol.Althoughpromisingresultshavebeenpublished,re‐searchontheeffectsofPTSLhasbeencriticizedonmethodologicalgrounds,suchasriskofselectionbiasandweaknessesinmeasuringworkparticipation.Todate,nosys‐tematicanalysisoftheevidencebaseontheeffectsofPTSLhasbeenundertaken.ObjectiveTheNorwegianLaborandWelfareAdministration(NAV)commissionedtheNorwegianInstituteofPublicHealthtomapallevidenceontheeffectsofpartialsickleave(PLSL)versusfull‐timesickleave(FTSL)onsicknessabsenceandworkparticipation.MethodWeconductedasystematicmappingreviewaccordingtointernationalstandards.Asystematicmappingreview(alsoknownassystematicscopingreview)isareviewthatmapsanddescribestheexistingliteratureorevidencebaseonaparticulartopic.Thereisnosystematicsynthesisofindividualstudyresults(e.g.,nometa‐analysis).Wein‐cludedstudiesinanylanguageevaluatingtheeffectsofPTSLversusFTSLonsicknessabsenceandworkparticipation.Eligiblestudydesignswereprospectivecontrolledstudiesaswellasregistry‐basedstudies(RBs).Theprojectteam(reviewers)andcom‐missioner(NAV)discussedandagreedontheresearchprotocol.Wesearchedeightmajordatabases,frominceptionto2018,contactedexperts,andhandsearchedwebsitesoflabororganizationsandministries,thebibliographiesofallincludedstudies,andliteraturereviewsinthefield.Twoindependentreviewers

  • 11 Executive summary (English)

    screenedtheretrievedreferencesanddataextractionwasdouble‐checked.Wecon‐ductedindependentqualityappraisaloftheincludedstudiesbyusingvalidatedcheck‐lists.Wegroupeddataextractedfromtheincludedstudiesaccordingtotheirchiefcharacteristics,performeddescriptiveanalyses,andpresentedtheresultsintextandtables.ResultsThirteenstudies,publishedbetween2010‐2017,metourinclusioncriteria.Allevalu‐atedtheeffectsofPTSLcomparedtoFTSLinsick‐listedemployees.WeincludedoneFinnishrandomizedcontrolledtrial(RCT)(n=62sick‐listedemployeesduetomusculo‐skeletaldisorders),and12RBs(n=2,742,497sick‐listedemployeesduetomainlymus‐culoskeletal‐ormentaldisorders).Theparticipantsinthe12RBswerefromNorway,Denmark,Finland,Sweden,andGermany.DifferentgradesofPTSLwereobservedacrossthestudies.IntheFinnishRCT,a50%PTSLwasgivento70%ofallsick‐listedemployees,whereas30%ofemployeesworkedshorterhourson3–4daysperweek.IntheRBs,themostcommonlyusedPTSLwas50%.TheRBsanalyzednationwideregistrydataonsicknessabsences(bothPTSLandFTSL)grantedbetween2001and2014,whichindicateda13‐years’timeline.Regard‐ingthestudies’methodologicalquality,theincludedRCThadmoderatequality,asdid11ofthe12RBswhileoneRBhadhighmethodologicalquality.ItisimportanttonotethatRBsdonotenableresearcherstoestablishcausalrelationshipsbetweenaninter‐ventionorexposureandoutcomes.SummaryofmainfindingsfromtheincludedstudiesSicknessabsence:TheFinnishRCTandthreeRBsreportedpositiveresultsofPTSLcom‐paredtoFTSLonsicknessabsenceatone‐yearfollow‐up.Workparticipation:Return‐to‐work:TheFinnishRCTfoundthatPTSLimprovedworkparticipationcom‐paredtoFTSLattheendoftheone‐yearfollow‐upperiod.AllofthenineRBsthatmeasuredworkparticipation,exceptoneNorwegianRB,showedfavorableassociationsinemployeesonPTSLcomparedtoFTSL.Unemployment:ThreeRBs–fromNorway,GermanyandFinland–reportedfavorableeffectsofPTSLcomparedtoFTSLonemployees’unemployment.Degreeofdisabilityandrehabilitationbenefits:Recurrenceofsickleaveforanycause:TheFinnishRCTfoundnosignificantdiffer‐encesbetweenPTSLandFTSLintherecurrenceofsickleaveforanycause.Disability:NodifferencesbetweenPTSLandFTSLwerereportedbytheFinnishRCTatone‐yearfollow‐upandinoneNorwegianRB,whereastwootherRBs(fromNorwayandFinland)foundthatPTSLwasassociatedwithimprovementsonemployees’disa‐bility.

  • 12 Executive summary (English)

    Productivityloss:OnlytheFinnishRCTreportedonproductivityloss.DatafromthisRCTshowedtherewasnosignificantdifferenceonproductivitylossbetweenPTSLandFTSLuptoone‐yearfollow‐up.Disabilitypension:OneNorwegianRBreportedthatPTSLwasassociatedwithahigherrateofreceivingdisabilitypensioncomparedtoFTSL,whereasthetwoGermanRBsre‐portedadecreasedriskofreceivingdisabilitypensioninemployeesonPTSL.AFinnishRBfoundthatPTSLwasassociatedwithalowerriskoffulldisabilitypensioncomparedtoFTSL,whereastheoppositeassociationwasfoundfortheriskofpartialdisabilitypension.Allowanceofsocialwelfarebenefits:FourRBsobservedthatPTSLwasassociatedwithalowerallowanceofsocialwelfarebenefitscomparedtoFTSL.Health‐relatedoutcomesOnlytwooftheincludedstudiesreportedonhealth‐relatedoutcomes.TheFinnishRCTfoundnodifferencesbetweenPTSLandFTSLonpainintensity,butshowedpositiveresultsforPTSLonbothself‐ratedgeneralhealthandhealth‐relatedqualityoflife.AGermanRBshowedthatPTSLwasassociatedwithbetterphysicalandemotionalfunctioninginsick‐listedemployees.TheFinnishRCTfoundnodifferencebetweenPTSLandFTSLonsick‐listedemployees’depressivesymptoms,whiletheGer‐manRBshowedthatPTSLwasassociatedwithimprovementsonbothdepressionandanxietysymptoms,andworkingability,whencomparedtoFTSL.ConclusionTheevidenceontheeffectsofPTSLcomparedtoFTSLconsistsofonesmallRCTand12RBs,withatotalofabout2.74millionstudyparticipantswithmostlymusculoskeletal‐ormentaldisorders.ThefindingsindicatePTSLmaybeassociatedwithseveralfavora‐bleoutcomes,suchashigherworkparticipation,butduetotheoverwhelmingmajorityofobservationalstudiesinthisbodyofevidence,firmconclusionsabouttheeffectsofPTSLcannotbedrawn.BothstudydesignssuggestedPTSLmaybeassociatedwithshortersicknessabsencedurationandhigherworkparticipation.TheFinnishRCTre‐portedthatemployeeswithPTSLexperiencedbettergeneralhealthandqualityoflifecomparedtothoseonFTSL.However,itdidnotfindstatisticaldifferencesbetweenPTSLandFTSLonsickleaverecurrence,employees’productivityloss,andpain.TheRBsindicatedalowerprobabilityforpeopleonPTSLofreceivingbothdisabilitypen‐sionandallowancebenefits,disability,aswellasbetterscoresonphysical‐andemo‐tionalfunctioning,anxiety,depression,andworkingability.FirmconclusionsabouttheeffectsofPTSLareconstrainedduetotheoverwhelmingmajorityofRBsinthisbodyofevidence.Observationaldesignshaveconsiderableriskofsystematicdifferencesintheresults,whichmakeitdifficulttoanswerquestionsaboutcauseandeffect.FurtherhighqualityRCTsarenecessaryinordertodrawfirmconclusions.

  • 13 Preface

    Preface

    TheNorwegianLaborandWelfareAdministration(inNorwegian:Arbeids‐ogvelferdsetaten,NAV)commissionedtheNorwegianInstituteofPublicHealth(NIPH)tomapoutallevidenceontheeffectsofpartialsickleavecomparedtofull‐timesickleaveonsicknessabsenceandworkparticipation.ThecommissionispartoftheongoingframeworkagreementbetweenNIPHandNAV.ThissystematicmappingreviewcanhelptoinformandsupportNAV,otherauthoritiesaswellasotherresearchorganizationsinevidence‐informeddeliberationsabouttheuseofpartialsickleaveforsick‐listedemployees.TheDivisionforhealthserviceswithintheNorwegianInstituteofPublicHealthfollowsastandardapproachinconductingsystematicmappingreviews,whichisdescribedintheNIPHhandbookSlikoppsummererviforskning.Wemayusestandardformulationswhenwedescribethemethods,resultsanddiscussionofthefindings.Contributorstotheproject:

    Projectcoordinator:JoseMeneses‐Echavez,researcher,NIPH Othercontributors:RigmorCBerg,Departmentdirector;NikitaBaiju,researcher,

    andresearchlibrarianElisabetHafstad,allfromNIPH.Declaredconflictsofinterest:Allauthorsfilledoutaformtodocumentpotentialconflictsofinterest.Noconflictsofinterestweredeclared.TheauthorswouldliketothankElisabetHafstad,researchlibrarianatNIPH,forhelpwithdevelopingthesearchstrategyandforrunningthesearchesinthemajordata‐bases,aswellasHeidNøklebyandDorisToveKristoffersen,bothseniorresearcherswiththeNIPH,fortheirassistancewithcheckingdataaccuracyandguidanceonstatis‐ticalanalysesintheprimarystudies.Wearegratefulforexpertpeerreviewbyprofes‐sorsArneMastekaasa,UniversityofOslo,andPiaSvedberg,KarolinskaInstitute.NIPHisresponsibleforthecontentsofthereviewpresentedinthisreport.Thecom‐missionerofthereviewandpeerreviewersbearnoresponsibility.

    KåreBirgerHagenResearchdirector

    RigmorCBergDepartmentdirector

    JoseF.Meneses‐EchavezProjectleader

  • 14 Abbreviations

    Abbreviations

    CBA,Controlledbefore‐afterstudyCI,ConfidenceintervalCochraneEPOCgroup,TheEffectivePracticeandOrganisationofCareGroupFRW,Fasterreturn‐to‐workFTSL,Full‐timesickleaveGNI,GrossnationalincomeGP,GeneralpractitionerHR,HazardratioIA‐avtalen,InkluderendearbeidslivavtalenITS,InterruptedtimeseriesMD,MentaldisorderMSD,MusculoskeletaldisorderNAV,theNorwegianLaborandWelfareAdministrationNIPH,NorwegianInstituteofPublicHealthNRCT,Non‐randomizedcontrolledstudy/Quasi‐randomizedstudyOECD,OrganisationforEconomicCo‐operationandDevelopmentOR,OddsratioPICO,Population,Intervention,Comparison,OutcomePRISMA‐ScR,PreferredReportingItemsforSystematicreviewsandMeta‐Analysesex‐tensionforScopingReviewsPTSL,Part‐timesickleaveRB,Registry‐basedstudyRCT,RandomizedcontrolledtrialRR,RiskratioRTW,Return‐to‐workSINTEF,StiftelsenforindustriellogtekniskforskningSLS,SemiparametricLeastSquaresanalysis

  • 15 Background

    Background

    Sicknessabsenceandtheneedtoincreaseworkparticipationinworkingagepeoplearecriticalprioritiesindevelopedcountries(1).Notonlydoesahighsicknessabsenceratehavesubstantialcostimplicationsforemployersandsocialsecuritysystems,sick‐nessabsenceaffectsworkers’well‐being,self‐esteemandlivelihood(2).Long‐termsicknessabsenceratesarehighinmanyOECDcountries(2).Norwayexhibitsacom‐parativelyhighrateofsicknessabsence(3),whichhasremainedalmostunchangedforthepastfiveyears(4;5).ThemostrecentdatapublishedbyStatisticsNorway(inNor‐wegian:Statistisksentralbyrå)indicatethesicknessabsencerateinthecountrywas6.5%adjustedforseasonalandinfluenzavariations(self‐anddoctorcertified)inthe3rdquarterof2017.Thisrateisconsiderablyhigherinfemales(8.3%)thaninmales(4.9%)(6).TheNordiccountrieshavesimilarsocialsecuritysystems,andingeneralterms,theyarerelativelysimilarintheirdataonsicknessabsence.However,comparisonsacrossthesecountriesareconstrainedduetodifferencesintheregistrationmethodsinthenationalregisters.Forexample,Swedendoesnotregistersicknessabsencesbelow15days(7).Overall,however,datafromtheNordicSocialStatisticalCommittee2015indi‐catethatNorwayandSwedenhavehighratesoflong‐termsicknessabsence,whereasshort‐termsicknessabsence(i.e.sicknessabsenceoflessthan8days)ishighinDen‐markandlowinNorway(7).Further,thereportstates“womenhavemoresicknessab‐sencethanmen.Olderemployeeshavemorelong‐termsicknessabsencethanyoungeremployees.Youngeremployeeshavemoreshort‐termsicknessabsencethanolderem‐ployees”(7).Togatherthemostup‐to‐datedataonsicknessabsenceinthefiveNordiccountries,weconsultednationalministriesandrelevantorganizations(table1).Briefly,Norwayex‐hibitsthehighestrateofsicknessabsenceintheregion.NorwayandDenmarkpaythehighestpercentageofsalarytotheirsick‐listedemployees(percentageofsicknessben‐efitcomparedtosalary),withthelowestpaymentbeingobservedinFinland.Thehigh‐estnumberofdaysawayfromworkbeforeamedicalcertificatemustbepresentedisseeninSwedenandFinland;whereasDenmarkandIcelandshowthehighestnumberofdaysinwhichtheemployerisresponsibleforpayingsicknessbenefits.

  • 16 Background

    Table1.DataonsicknessabsenceacrosstheNordiccountriesSickleavedata Norway Denmark1 Finland3 Iceland4 Sweden5

    Sicknessabsence 6.5%inthe3rdquarterof2017

    3.7%in2014‐2015

    Ca5%in2015 1‐2%in2006 2.9%inthe3rdquarterof2017

    Numberofdaysawayfromworkbeforeamedicalcertificatemustbepresented

    3days 2days 0‐7days

    3days 7days

    Forhowlongcantheemployeebeoffsickbeforelosingsick‐ness‐benefits?

    260days(52weeks)

    22weekswithin9months.Bene‐fitscanbepaidforalongerpe‐riodifthere‐cipientfulfilstheprolonga‐tioncondi‐tions1

    300days(ex‐cludingSun‐days)overa2‐yearperiod(forthesameillness).120daysforpartialsickness(ex‐cludingSun‐days)overa2‐yearperiod2.

    52weeksovera2‐yearpe‐riod.Foreachmonthworked,anemployeeisentitledtowagesfortwodaysofsickleave.Thegen‐eralruleisthatthesickleaverightsofem‐ployeesin‐creasethelongertheyworkforthesameem‐ployee.

    From1Febru‐ary2016,thetimelimitwasabolishedinthesicknessbenefitsystem.Hence,thereisnolongeramaximumtimeforhowlonganemployeecanbeoffsick.

    Percentageofsick‐nessbenefitcom‐paredtosalary

    100% 90‐100%Sicknesscashbenefit(syged‐agpenge)cal‐culatedbasedonthehourlywageoftheemployee,withamaximumofDKK4,245(€571)perweekorDKK114.73(€15.43)perhour(37hoursperweek),andonthenumberofhoursofwork2

    Ca70%

    Asetfigureir‐respectiveofsalary.Today,governmentpaysIKR1746perday,plusIKR480pereachchildsup‐portedbythepersonreceiv‐ingthebenefits(theamountisdecidedbyministryregu‐lation).

    Ca80%

    Numberofdaysbe‐forebenefitstartsbeingpaid

    None None None None 1

    Numberofdaystheemployerisrespon‐sibleforpayingsick‐nessbenefit

    16days 30days2 10workingdays(includingSaturdays)

    1month 14days

    1. DanishdataprovidedbytheDanishAgencyforLaborMarketandRecruitment(STAR)viaemailcommunication(12/02/18).

    2. DatafromMISSOC,the“MutualInformationSystemonSocialProtection”.3. FinnishdataconfirmedbyEiraViikari‐Junturaandcolleaguesviaemailcommunication(07/03/18).4. IcelandicdatawerepartiallyconfirmedbytheIcelandicHealthInsuranceviaemailcommunication(15/03/18).5. SwedishdataconfirmedbytheMinistryofHealthandSocialAffairsviaemailcommunication(12/02/18).InNorway,employeesareentitledtosicknessbenefitsfromdayoneiftheyhavebeeninpaidworkforthelastfourweeksbeforethesicknesscasestarts(8).Theemployeris

  • 17 Background

    responsibleforpayingthefirst16daysofleave,andthereafterNAVassumesthepay‐ments.Theemployerdesignsafollow‐upplanwithinthefirst4weeks,andameetingwiththesick‐listedemployee,NAV,andthegeneralpractitioner(GP)isarrangedtodis‐cusssolutionsforreturntowork,ensuredialogueandupdatethefollow‐upplan.Asimilarmeetingisalsoorganizedat26weeksofsickleave.Afteroneyearonsickleave,theemployeemaybegrantedatransitionbenefitforuptofouryears(8;9).AlthoughtheapproachestoreducesicknessabsenceintheNordiccountriesvaryduetostructuraldifferencesandvariationsinsicknesspolicies,thecountriesarerelativelycomparablewithregardtotheirpoliciesrelatedtoitandmeasurestoreducesicknessabsence,ascomparedtomanyothercountries,usinginitiativesthatarebasedonclosefollow‐upofthesick‐listedperson.However,alackofevidenceregardingtheeffectsofthosemeasureshasbeenreportedintheliterature(10;11).SomeoftheNordicmeasurestoreducesicknessabsenceanddisabilitypensionincludethefollowing:re‐turntoworkprogram(Denmark),chartingofthepossibilitiesofthelong‐termsicklistedemployees’returntowork(Finland),rehabilitationchain(Sweden),andtheuseofpartialsickleave(possibleinallNordiccountries)(7).Partialsickleave(PTSL),alsocalledgradedsickleave,hasbeenconsideredthefirstop‐tiontotackleincreasingsicknessabsenceratesandtopreventlabormarketexclusion,especiallyintheNordiccountries(3).Accordingtoarecentreport(7),PTSLisunder‐stoodasagradedleave,whichallowspeoplewithreducedworkabilitytoworkparttimeandkeepthelinktothelabormarket.Thatis,itenablesemployeestoreturntomodifieddutiesattheworkplace,andmightfacilitateaprogressivereturntowork(7;12).Anunderlyingpremiseistheexpectationthatworking,andstayingconnectedtotheworkplace,initselfwillcontributetoreducedsickleaveduration(13).PTSLvar‐iesbetween20%upto99%,independentoftheproportionofemployment(8).InNor‐way,useofPTSLgainedtractionafterthe2004restructuringofthenationalsickleaveregulations.Inmostcases,wheneveranemployedpersonaskedforsickleave,theGPshouldconsiderPTSLthedefaultoption(13).AsimilarsituationdevelopedinSwedenafteradvicebythenationalgovernmentintheearly2000stoincreaseuseofPTSL.In2016,PTSLrepresentedaround34%ofallsickleavecasesamongwomenand26%ofthecasesamongmen(14).InNorway,theaimtoreduceratesofsickleavethroughimprovedinclusionmecha‐nismssuchasPTSLisanchoredinthecollectiveagreementoninclusiveworkingcondi‐tions(InNorwegian:Inkluderendearbeidsliv,IA‐avtalen).IA‐avtalenisacollaborativeagreementbetweentheNorwegiangovernmentandsocialpartners.Theagreement,firstsignedin2001,hasbeenrenewedseveraltimes,mostrecentlyin2014forthepe‐riod2014–2018(15).Importantly,the2010agreementstatedthefollowingthreemainobjectives:toreducesickleavesothatsicknessabsencewillnotexceed5.6%,toin‐cludemorepeoplewithreducedfunctionalabilitiesintoworkinglife,andtogetpeopletoretirelater(16).Participationintheagreementisvoluntaryforthecompaniesthatmayormaynotchoosetosigntheagreementandbecomeaso‐called‘IA‐company’(7).TheIA‐agreementincludesthefollowingfivemeasures(7;16):

    1. IncreaseduseofPTSL

  • 18 Background

    2. Changesintheroleofthesickleavecertifier(e.g.,training,feedbackonownpracticesandprofessionalguidanceintheworksurroundingauthorizedsickleave)

    3. EnterprisesandbusinessescanbemembersoftheIA‐agreement4. TheFasterReturn‐to‐Work(FRW)scheme5. Changesinthefollow‐upschemesofsick‐listedemployees

    Withregardtopointfour,theFasterReturn‐to‐Work(FRW)scheme(InNorwegian:Raskeretilbake)isacollectionofmeasuresthatintendedtopreventunnecessarylong‐termsickleave(7).Theschemeimpliesoffersonindividualfollow‐up,clarificationandwork‐orientedrehabilitation;offerfortreatmentatspecialisthealthservices(purchaseofhealthservices);andlegislativeamendmentstoensurecloserfollow‐upofsickpeo‐ple.Thus,theFRWschemeisbasedontheintentionthatsick‐listedemployeesgetfasterclarification,follow‐upandwork‐orientedrehabilitationthroughNAV.TheDirec‐torateofHealthandtheLaborandWelfareDirectorateareresponsiblefortheimple‐mentationofthescheme(17).Totesttheideathatanassessmentoffunctionalabilitiescouldstrengthenthepatient’sresources,whichinturncouldfacilitateandencourageanearlyreturntotheworkplace,aNorwegianclusterrandomizedcontrolledtrialwasconducted(18).ItevaluatedtheeffectsofteachingGPsaboutstructuredfunctionalas‐sessmentstochangetheirsick‐listingpractice,especiallyinprescribingmorePTSL.ThestudyresultsshowedthattheinterventionGPsprescribedPTSLmoreoften(oddsratio[OR]1.3,p

  • 19 Background

    showedimprovementsonworkinglifeinthecountryaftertheIA‐agreement,andcon‐cludedthattheIA‐companiesfulfilledalltheirobligationswithintheagreement,andexhibitedbettercooperation(e.g.,betterassistancefromworkinglifecentersandmorefocusonclosefollow‐upofpersonsonsickleave).Nevertheless,theevaluationfoundnoeffectsonsicknessabsenceamongIA‐companies,andseveralmethodologicaldiffi‐cultieswerediscussed(22).Continuingitsinterestsinreducingsicknessabsenceinthecountry,theNorwegianMinistryofLaborarrangedameetingwithscientistsandexpertsinApril2013inordertodiscussandreviewtheevidenceregardingthedifferentmeasurestheIA‐agreementimplied(16).AttendeeshighlightedthelackofempiricalresearchontheIA‐agreementmeasures,andencouragedfurtherresearchinthearea.Afterreviewingdatafromdif‐ferentregistriesandstudiesderivedfromthem,expertsobservedthatthesicknessab‐senceratesdecreasedintheperiodswhenuseofPTSLincreased.ThedecreasewaspartiallyattributedtoanincreasedpreferenceamongGPstowardsgradedsickleave(16).Inaddition,employeesonlong‐termsickleavelistedwithGPswhooftenusedPTSLexhibitedshortersicknessabsenceandahigherprobabilityofremainingem‐ployedtwoyearslater.Someexplanatorymechanismsdiscussedbytheexpertswerehealthbenefits,reducedriskofexpulsionfromworkandaneffectofPTSLonem‐ployee’sdisciplineandattitudetowork(16).Recentregistry‐basedanalysespublishedbyNAVobservedthatuseofPTSLdoubledintheperiod2002‐2016.Halfofthesick‐nessabsencecasesgrantedin2016weregradedsickleave,withhalfofthemgradedat50%.However,PTSLofbothhigherandlowerlevelsaremorecommonlyusedovertime.AquarterofpeopleonPTSLmoveontofulltimesickleave(FTSL),andtheriskofmovingontoFTSLishighestinthefirstfewweeksofthesicknessabsenceperiod.Moreover,theresearchersfoundthatwhilethedurationofsicknessabsencehasre‐mainedfairlystableovertime,theuseofPTSLoccursearlierthanbeforeinthecourseofthesicknessabsence,withmostofthecasesgradedalreadyfromthefirstdayofab‐sence(13).TherehavebeendebatesontheeffectsoftheincreasedemphasisonPTSL.EmpiricalresearchonPTSLhasshownlargelypromisingresults,especiallyintheNordiccoun‐tries.Forexample,datafromaFinnishnationwideregistry‐basedstudyshowedbenefi‐cialeffectsofPTSLcomparedtoFTSLonreturntoworkandworkparticipation(23).PTSLhasalsobeenassociatedwithincreasedworkretentionanddecreaseduseoffulldisabilitypensioninlong‐termassessmentsinFinland(24).Similarfindingswerere‐portedinatrialamongFinnishworkerswithmusculoskeletaldisorders(MSDs)(25).InNorway,Kannandcolleagues(26),foundadeclineintheproportionofindividualsonsickleavewhentherateofPTSLincreased,aswellasshortersicknessabsencedura‐tion.DatafromanotherNorwegianregistry‐basedstudy(27)indicatedthatsick‐listedemployeeswhowereonPTSLwhentheycompletedawork‐relatedrehabilitationpro‐gramweremorelikelytoreturntoworkcomparedtothosewhowereonFTSLwhentheylefttherehabilitationclinic.InSweden,PTSLwasfoundtobeassociatedwithanearlierreturntoworkinpeoplewithmentaldisorders(MDs)after60daysofFTSL(28),whilstnoeffectofPTSLonearlyreturntoworkwasobservedamongpeoplewithMDsinanotherstudyconductedinDenmark(29).Grasdal(30),whoreviewedahand‐

  • 20 Background

    fulofempiricalstudiespublishedpriorto2016,concludedthatoverall,theresultsindi‐catedthatPTSL“contributestoreductioninsicknessabsence.Specifically,gradingseemstocontributetoreducingthesickleaveperiod,butthereisconsiderableuncer‐taintyaboutthesizeofthiseffect”(p.114).Althoughnotablepromisingresultshavebeenpublished,researchontheeffectsofPTSLhasbeencriticizedforhavingweakexternalvalidity,andmethodologicalflaws,suchasselectionbias,highuseofself‐reporteddata,andweaknessesinmeasuringworkparticipation(1;31).Todate,nosystematicanalysisoftheevidencebaseontheeffectsofPTSLcomparedtoFTSLhasbeenundertaken.Therefore,thissystematicmappingreviewaimedtomapallquantitativeevidenceontheeffectsofPTSLversusFTSLonsicknessabsenceandworkparticipation.

  • 21 Methods

    Methods

    Weconductedasystematicmappingreviewtoanswerthequestion:whatevidenceex‐istsandwhatdoesitsayabouttheeffectsofPTSLversusFTSLonsicknessabsenceandworkparticipation?Theprojectteam(reviewers)andcommissioner(NAV)discussedandagreedontheresearchprotocol,whichisavailableuponrequest.

    Whatisasystematicmappingreview?

    Systematicmappingreviews(alsoknownassystematicscopingreviews)arereviewsthatmapanddescribetheexistingliteratureorevidencebaseonaparticulartopic(32).Suchliteraturereviewstakestockoftheresearchavailableinaparticularfield.Thistypeofreviewproducesausefulendproductinitsownright,describingtheem‐piricalresearchthathasbeenundertakenwithinaparticularfieldofstudy,butalsoprovidesanoverviewofaresearcharea,highlightingwhereempiricalresearchislo‐catedandwheretherearegaps.Itdoesnotincludeasynthesisofindividualstudyre‐sults(32;33).Inatypologyofreviews,GrantandBooth(34)explainthatsuchreviews“mapoutandcategorizetheexistingresearchonaparticulartopic,identifyingresearchgapsfromwhichtocommissionfurtherreviewsand/orprimarystudies.”ThepresentmappingreviewwasmethodologicallyguidedbyaframeworkproposedbyArkseyandO’Malley(32),aswellasLevacandcolleagues’(35)recommendationsonclarifyingandenhancingeachstageofthereview.Thus,themethodologicalstepswere:

    1.Identifyingtheresearchquestion2.Identifyingrelevantstudies3.Selectingstudies4.Chartingthedata5.Collating,summarizingandreportingtheresults6.Optionalconsultation.

    Asseenfromthisoutlineofthemethodologicalstepsofsystematicmappingreviews,qualityappraisalisnotadefinedstepwithinsuchreviews(32;33).However,wede‐cidedtoappraisethemethodologicalqualityoftheincludedstudiesuponagreementwiththecommissioner(NAV).Qualityappraisalwasperformedaspartofstep4,chart‐ingthedata.ThissystematicmappingreviewisreportedinaccordancewiththePRISMA‐ScRreportingguideline(36).

  • 22 Methods

    Selectioncriteria(identifyingtheresearchquestion)

    Theselectioncriteriawerediscussedandagreedwiththecommissioneraheadoftheliteraturesearch.WeincludedquantitativeresearchaddressingtheeffectsofPTSLver‐susFTSLonsicknessabsenceandworkparticipation.Themainstudyinclusioncrite‐rionwasasubstantialemphasisontheeffectofPTSLversusFTSLasthesubjectmatter.TheselectioncriteriawereguidedbythefollowingPICO(population,intervention,comparison,andoutcome)elements:Population:Part‐timeorfull‐timeadultemployees(16‐69yearsold).Weexcludedstudiesofpeoplewhoweredescribedasself‐employed.Intervention:Partialsickleave(PTSL).Followingthe2015reportbytheNordicSocialStatisticalCommittee(7),wedefinedPTSLasgradedleave,thatallowspeoplewithre‐ducedworkabilitytoworkparttime.PTSLvariesbetween20%upto99%(7;12).WepresentanydifferencesintheconceptualizationofPTSLacrosstheincludedstudiesintheresults.Comparison:Full‐timesickleave(FTSL),i.e.,nophysicalpresenceattheworkplace.Outcomes:

    Sicknessabsence(extent,duration,andsimilar):man‐dayslostduetoownsick‐nessasapercentageofcontractualman‐days(6).Oneman‐daycorrespondstothelengthintimeofoneworkingdayforapersoninafull‐timeposition(100%position).Workparticipation(extent,beingfired,andsimilar)measuredaspositionpro‐portion(valuesmightrangebetween0to1)(6).Degreeofdisabilityandrehabilitationbenefits:whetherthepersoninques‐tionisonfull‐orPTSL,andtowhatdegree,isindicatedbythedegreeofdisability.Thedegreeofdisabilityisbetween20%and100%,where100%meansfulldisa‐bility.Ifasicknessabsencecaseconsistsofmorethanonemedicalcertificate,re‐searchersmightreporttheaverageofthedegreesofdisabilityforthemedicalcertificatesinquestion(6).Health‐relatedoutcomes:Diseaseseverityanddisability.

    Studydesign:Duetothefactthatthiscommissionwastiedtoaneffectivenessques‐tion,weaimedtoincluderandomizedcontrolledtrials(RCTs)aswellasnon‐random‐izedstudieswithacontrolcondition.Weincludednon‐randomizedstudiesbecauseweanticipatedthatfew,ifany,RCTshadbeenconductedinthisfield.Registry‐basedstudies(RBs)(alsoknownaspaneldataanalysis)wereincludedinthisreviewafterroundsofconsultationwiththecommissioner.RBsinvolvethestatisticalanalysisofdatasetsfromregistriescontainingmultipleobservationsovertimeofasamplingunit(37).RBscanbeconductedbypoolingtime‐seriesobservationsacrossavarietyofcross‐sectionalunits,includingindividuals,countries,orcompanies(37;38).

  • 23 Methods

    However,thesestudiesdonotenableresearcherstoestablishcausalrelationshipsamonganinterventionorexposureandoutcomes(38).Insum,weconsideredthefollowingstudydesignsforinclusion:

    Randomizedcontrolledtrials(RCT) Non‐randomizedcontrolledstudies/Quasi‐randomizedstudies(NRCT) ControlledBefore‐Afterstudies(CBA) InterruptedTimeSeries(ITS)withatleastthreemeasurementpointsbefore

    andaftertheintervention Registry‐basedstudies(RBs)

    Wefollowedthedefinitionsofnon‐randomizedstudiesproposedbytheEffectivePrac‐ticeandOrganisationofCareCochraneGroup(39)(seeGlossaryinAppendix1).Publicationdate:Studiespublishedbetween1990and2018.Language:WeincludedalllanguagesaslongastherewasanabstractinEnglish.Anystudiesmeetingtheinclusioncriteriaandpublishedinlanguagesnotmasteredbythereviewteam(English,Spanish,Norwegian,Swedish,Danish,German)wouldhavebeentranslatedwithGoogletranslateorbyacolleagueattheNIPH.Context:Studiesconductedinhigh‐incomeeconomies(GNIpercapitaof$12,236ormore)asdefinedbytheWorldBank(Link:https://data‐helpdesk.worldbank.org/knowledgebase/articles/906519‐world‐bank‐country‐and‐lending‐groups).Literaturesearch(identifyingrelevantstudies)

    Afterextensivedialoguewiththecommissionertoagreeontheresearchquestionandtheselectioncriteria,aresearchlibrarian(ElisabetHafstad)plannedandexecutedsys‐tematicsearchesinthefollowingdatabases(frominceptiontoJanuary2018):

    CochraneLibrary:CENTRAL Embase MEDLINE PsycINFO PubMed SociologicalAbstracts&SocialSciencesAbstracts SveMed+ WebofScience

    Thesearchstrategywasadaptedforeachdatabase.Thefinalsearchstrategyispro‐videdinAppendix2.SearchingothersourcesToidentifyadditionalstudies,wehandsearchedthebibliographiesofallincludedstud‐ies,aswellasanyliteraturereviewsandseminalreportsaboutPTSL.Wesearchedthe

  • 24 Methods

    websiteoftheNorwegianInstituteofPublicHealth,Idunn(NordicJournalsonline),theNorwegianandNordicindextoperiodicalarticles(Norart),OpenGrey,Google,andGoogleScholarandscreenedthefirst200hits.Tworeviewers(JM,RB)alsohandsearchedontheNordicLabourJournal(http://www.nordiclabourjournal.org/),theCampbellLibraryandthefollowingwebsites:Nordicorganizationsforlaborandworkenvironment

    • TheDanishNationalResearchCentrefortheWorkingenvironment• TheDanishAgencyforLaborMarketandRecruitment• FinnishInstituteofOccupationalHealth• TheNorwegianLaborandWelfareAdministration(NAV)• TheNorwegianMinistryofLaborandSocialAffairs• Försäkringskassan(Sweden)• TheSwedishMinistryofHealthandSocialAffairs

    Ongoingandrecentlycompletedclinicaltrials

    WorldHealthOrganizationInternationalClinicalTrialsRegistryPlatform(http://www.who.int/trialsearch/)

    NationalInstituteofHealthclinicaltrialsdatabase(http://clinicaltrials.gov)Studyselection

    Allrecordsretrievedthroughtheliteraturesearcheswereindependentlyscreenedforeligibilityagainsttheselectioncriteriabytworesearchers(JMandNB)byusingapre‐designedscreeningform.Wefirstscreenedtitlesandabstractsandthenproceededtofull‐textscreeningofrelevantrecordstodecidefinalinclusionorexclusion.Inclusionwasdecidedbyconsensusandanydiscrepanciesweresolvedbydiscussion.Ifneces‐sary,wewouldhaveinvolvedathirdresearcher(RB)tosolvediscrepancies.Dataextraction(chartingthedata)

    Wedesignedadataabstractionformtogatherrelevantinformationfromeachstudy,includingcharacteristicsofstudyparticipants,settings,context,percentageofsickleaveevaluatedinthestudy,comparisons,studydesigns,methods,statisticalanalysesandcovariates,andresults.Onereviewer(JM)extractedalldatafromtheincludedstudiesandasecondreviewer(NB)checkedtheinformationforaccuracyandcom‐pleteness.HNandDTKassistedwithcheckingdataaccuracy.Disagreementsweresolvedbydiscussion,consensus,andparticipationofRB.Qualityappraisaloftheincludedstudies

    Tworeviewauthors(JM,NB/RB)appraisedthemethodologicalqualityofeachin‐cludedstudyindependently.Weresolveddisagreementsbyconsensus.Ifnecessary,wewouldhaveinvolvedanotherresearcher.

  • 25 Methods

    RCTswereappraisedbyusingtheCochranetoolforassessmentofriskofbiasofRCTs(40).Thus,weassessedthefollowingcriteria:

    •Randomsequencegeneration(selectionbias).•Allocationconcealment(selectionbias).•Blinding(performancebiasanddetectionbias),blindingofparticipantsandpersonnelassessedseparatelyfromblindingofoutcomeassessment.•Incompleteoutcomedata(attritionbias).•Selectivereporting(reportingbias).•Otherbias.

    WecriticallyappraisedtheRBsbyusingthechecklistforcohortstudiesdescribedintheNIPHhandbook‘Slikoppsummererviforskning’(41).This10‐itemschecklistevalu‐atesknownsourcesofbias,suchasselectionbias,incompleteorlackofreportingofoutcomeassessment,dropouts,confoundingfactors,andblindingofoutcomeassess‐ment.WeusedthistoolbecauseitisthemostsuitableappraisaltoolwecouldidentifyforRBs.Wesearchextensivelyandaskedmethodologicalexperts,andtheirrecommen‐dationwastousethechecklistforcohortstudies.IthasbeenusedbyustoappraiseRBsinprevioussystematicreviews.Whilethischecklisthaslimitations,tothebestofourknowledge,thereisnouniquechecklistforappraisingRBs.Intheeventthatnon‐randomizedcontrolledstudies,includingCBAsandITSs,hadbeenincluded,wewouldhaveappraisedthemethodologicalqualityofsuchstudieswiththetoolsuggestedbytheCochraneEPOCGroup(42).Thistoolincludesadditionalitems(relativetotheCochraneriskofbiastoolforRCTs)toassesstheriskofselectionbiasandsubsequentconfounding.Theadditionalitemsare“werebaselineoutcomemeas‐urementssimilar?”and“werebaselinecharacteristicssimilar?”(42).Collatingandsummarizingtheresults

    Asdescribedabove,mappingreviewsprovideanoverview‐anddescriptionofexistingresearch.Datasynthesisislimited,relativetofullsystematicreviews:Asystematicmappingreviewdoesnotincludeasynthesis,suchasmeta‐analysis,ofindividualstudyresults.Inaccordancewiththeaim‐andmethodologicalscopeofsystematicmappingreviews,weanalysedthedatadescriptively,withfrequenciesandpercentages,andpresentedresultsintext,tables,andfigures.Wegroupedstudiesintocategoriesac‐cordingtohowtheywereseentorelatetoeachother,followingadatadrivenap‐proach.Forclarity,wepresentedinformationseparatelyforRCTsandRBsaswellasresearchfromNordiccountries.WenotethatRBsdonotenableresearcherstoestab‐lishcausalrelationshipsamonganinterventionorexposureandoutcomes.

  • 26 Results

    Results

    Searchresults

    Theelectronicsearchesinthemajordatabasesyielded676references,andadditionalsearchesingreyliteraturesourcesadded30references.Atotalof300duplicateswereremoved.Weexcluded380outofthe406referencesscreenedattitle/abstractlevel,andwereadtheremaining26referencesinfull‐text.Thirteenstudiesmetourinclusioncriteria.Threeoutofthe13includedstudieswereidentifiedafterconsultinglaboragenciesandinternationalministries(15;43;44).Figure1depictstheflowdiagramfortheselectionofthestudies.Norelevantongoingstudieswereidentifiedbysearchinginthetrialregistries.Thein‐terventionsunderevaluationintheregisteredprotocolsaboutreturn‐to‐worktrialsin‐cludedbehavioralinterventions,self‐management,psychotherapy,motivationalinter‐viewing,andotherintegratedactivereturn‐to‐workprograms.Excludedstudies

    Mostofthe13excludedstudiesreadinfull‐texteitherdidnotevaluatetheeffectsofPTSLorwerenotempiricalresearch.ANorwegianRCTthatevaluatedactivesickleavedidnotmeettheinclusioncriteriaastheauthorsexcludedemployeesonpartialsickleave(45).Thistrialfoundthatactivereturn‐to‐workimprovedneitherthenumberofdaysonsickleavenortheproportionofpatientsreturningtoworkinworkerswithlowbackpainfrom65Norwegianmunicipalities(45).Additionally,twoNorwegianRBswereexcludedbecauseofthelackofacomparisongroupwhowereonFTSL.Thesetwostudiesevaluatedsolelydatafromsick‐listedemployeeswhoreceivedPTSL(26;46).Weprovidethemainreasonsforexclusionofthe13referencesexcludedafterfull‐textconsiderationinAppendix3.

  • 27 Results

    Figure1.Flowdiagramoftheselectionofstudies Descriptionofincludedstudies

    Theevidencepresentedinthissystematicmappingreviewconsistsof13studies.WeincludedoneRCTfromFinland,reportedintwopublications(25;47),whiletheremain‐ing12studieswereRBs(1;15;17;24;28;43;44;48‐52).Thesestudiesusedobserva‐tionalmethodstoexploretheinteractionsbetweenPTSLanddifferentvariables,suchasreturn‐to‐work(RTW),insetsofpaneldatafromregistries.ResearchaimOverall,all13includedstudiesexaminedtheeffectsofPTSLcomparedtoFTSLforsick‐listedemployees(table2).

    References screened at title and abstract (n = 406) 

    References identified from the  database searches 

    (n = 676) 

    Additional references identified from other sources  

    (n = 30) 

    References after duplicate removal (n = 406) 

    References excluded (n = 380) 

    References screened in full‐text (n = 26) 

    References excluded  (n = 13) 

    Included studies  (n = 13) 1 RCT 12 RBs 

  • 28 Results

    RandomizedcontrolledtrialResearchersoftheFinnishInstituteofOccupationalHealthconductedtheonlyRCTin‐cludedinthismappingreview.Thetrial,whichfollowedaprospectiveparalleldesignandwasreportedintwodifferentpublications,evaluatedtheeffectsofearlyPTSLonRTWandsicknessabsence(25),andonhealth‐relatedoutcomes(47)amongworkerswithMSDs.Registry‐basedstudiesAllthe12includedRBsevaluatedtheeffectsofPTSLcomparedtoFTSLforsick‐listedemployees.WenotethattwoGermanstudiesevaluatedemployeeswhocompletedarehabilitationprogram,whichismandatoryinthecountry(17;50).Twootherstudies,fromFinland,addressedthetransitiontodisabilitypension(24)andtheintroductionofnewlegislationofPTSL(1).Lastly,oneRB(24)hasacompanionpaperwithanalysesofthesamedataset,whichweappliedwhenrelevant(23).Setting

    Ingeneral,itcanbestatedthatmostoftheevidencebaseontheeffectsofPTSLcomesfromNordiccountries,as11studies(85%)weredoneinsuchsettings(1;15;24;25;28;43;44;47‐49;51).ThetworemainingRBswereconductedinGermany(17;50).Seetable2. Table2.Countryandresearchaimoftheincludedstudies(n=13)Study,year Country ResearchaimAndrén2012(48)

    Sweden ToexaminethebenefitsofbeingonPTSLcomparedtoFTSLinindividualswithmusculoskeletaldisorders.

    Andrén2014(28)

    Sweden ToanalyzetheimpactofPTSLontheprobabilityofreturningtoworkwithfullrecoveryoflostworkcapacitywithin1yearforemployeeswithmentaldisorders.

    Bethge2016(17)

    Germany TodeterminetheeffectsofPTSLondisabilitypensionandreg‐ularemploymentinarandomsampleofrehabilitationpatientswhofinishedarehabilitationprogrambetween2002and2009.

    Grødem2015(15)

    Norway Tostudyemployeeswhocompletedtheirperiodofsicknessbenefits(2‐3yearsaftercompletion)butarestillunabletofullyreturntowork.

    Høgelund2010(52)

    Denmark Toexaminetheeffectofanationalgradedreturn‐to‐workpro‐gramontheprobabilityofsick‐listedworkersreturningtoreg‐ularworkinghours.

    Kausto2012(24)

    Finland ToestimatetheeffectsofPTSLonthe transitiontodisabilitypensionapplyingpropensityscoremethods.

    Kausto2014(1) Finland ToexaminetheeffectsofthenewlegislationonPTSLonworkparticipationofemployeeswithlong‐termsicknessabsence.

    Lie2014(43) Norway ToevaluatetheeffectsofPTSLvsFTSLonsicknessabsence.Markussen2012(49)

    Norway ToexaminewhetherPTSLcanreduceabsenteeismandsubse‐quentsocialinsurancedependency,andpromoteself‐suffi‐ciency.

    Nossen2013(44)

    Norway ToexploretheroleofdifferentdefinitionsofPTSLcomparedtoFTSLonsicknessabsenceduration.

  • 29 Results

    Shiri2013(47)Viikari‐Juntura2012(25)RCT

    Finland Todeterminethehealth‐relatedeffectsofearlyPTSLamongemployeeswithmusculoskeletaldisorders(47).ToevaluatetheeffectsofearlyPTSLonreturntoworkandsicknessabsenceamongpatientswithmusculoskeletaldisor‐ders(25).

    Streibelt2017(50)

    Germany TodeterminetheeffectofPTSLinadditiontoamultimodalre‐habilitationprogramonlong‐termworkparticipationinpeoplewithchronicmentaldisorders.

    Viikari‐Juntura2017(51)

    Finland ToassesstheeffectivenessoftheuseofPTSLattheearlystageofworkdisability(first12weeks)duetomentaldisorderormusculoskeletaldiseaseonsustainedreturntowork(RTW)andoverallworkparticipation.

    Typeofpublicationandpublicationyear

    Mostofthestudiesincludedinthissystematicmappingreviewwerepublishedinpeer‐reviewedjournals(11studies,85%).TwoNorwegianRBswerepublishedasorganiza‐tionalreports(15;43).TheFinnishRCTwaspublishedin2012‐2013(25;47).TheRBswerepublishedbetween2010and2017,withmostpublishedaround2014.ParticipantsBelow,wepresentthecharacteristicsoftheparticipantsintheRCTandRBsseparately.RandomizedcontrolledtrialTheFinnishtrial(25;47)included62employeesonsickleaveduetoMSDs.Theywererecruitedfromsixoccupationalhealthunitsofmedium‐andlarge‐sizeprivateorpublicenterprises.Theyhadapermanentorlong‐termcontract,workingfull‐time(37‐38hoursperweek),andhadnotbeenonsickleaveduetotheirMSDsfor>2weeksduringtheprecedingmonthand>30daysduringthepreceding3months.Mostofthepartici‐pantsworkedinthehealthcaresectororretailtrade,andaminorityfromcall‐centresormeat‐processingindustry.Aroundhalfoftheparticipantshadhighervocationalschoolbutnoneofthemhadcompleteduniversitystudies(table3).Table3.Characteristicsofparticipants,interventionandcontrolgroupintheFinnishrandomizedcontrolledtrialRandomizedcon‐trolledtrial(RCT)

    Population Intervention:Part‐timesickleave,

    PTSLN(%)

    Comparison:Full‐timesickleave,FTSLN(%)

    Viikari‐Juntura2012(25),Shiri2013(47)Finland

    N=62employeesAge:meanage44(standarddeviation10)Sex:97%femaleDiagnosis:Musculoskeletaldisorders(e.g.,neckorshoul‐derregion,backorupperorlowerextremities)Ethnicity:notreported

    N=31(50%)70%received50%PTSL30%workedshorterhourson3–4daysaweek

    N=31(50%)

  • 30 Results

    Registry‐basedstudiesTheparticipantsinthetwelveregistrystudieswerefromNorway(fourstudies),Den‐mark(onestudy),Finland(threestudies),Sweden(twostudies),andGermany(twostudies).Intotal,2,741,563participantswereanalyzedintheseRBs(range627–1,400,094).Ingeneralterms,thevastmajorityofparticipantsacrosstheRBssharedcommoncharacteristics,suchashavingaregularjobcontract,beingfemale(upto78%)andaround45yearsold(range18‐64).GrødemandcolleaguesincludedNorwe‐gianemployeesolderthan60(15),whileLie(43)andNossenandBrage(44)didnotprovideinformationonparticipants’age,genderordiagnosis.OnlythetwoSwedishstudiesprovideddataonparticipants’ethnicity(28;48).Seetable4.NationalregistriesusedforanalysisAlltwelveRBsuseddatafromnationalregistries.ThefourstudiesconductedinNor‐wayallutilizeddatafromtheNorwegianLaborandWelfareAdministration(NAV),asfollows:

    Markussenanalyzeddatafromallsicknessabsencesgrantedfrom2001through2005(49).

    NossenandBrageanalyzeddatafromallspellsgrantedin2011(44). Lie(43)analyzeddatafromspellsgrantedto10%ofallpeoplereportedinNAV’sregistryduring2002‐2010.

    Grødem(15)analyzeddatafromemployeeswhoterminatedthesicknessbenefitsperiodduringthefirsthalfof2011afteroneyearofsickleave.

    ThissuggestssomeoverlapinthecasesbasedontheNAVregistry,betweenLie(43)andMarkussenandcolleagues(49)andbetweenNossenandBrage(44)andGrødemandcolleagues(15).Weprovidefurtherdescriptionsinthesection“partialsickleaveintheincludedstudies”below.Therewerenoindicationsofoverlapbetweendatasourcesintheremainingstudies.Andrénandcollaboratorsusedthesamedatasetfromthe2002sampleoftheSwedishSocialInsuranceAgencycontainingdataofsick‐listedemployeesduetoMSDs(48)andmentaldisorders(MDs)(28).Høgelundandcol‐leaguesuseddatafromthenationalregisterofpaymentsofsicknessbenefitsinDen‐mark,supplementedwithsurveyinformation(52).InthetwoGermanstudies,Bethgeandcolleagues(17)studiedemployeeswhocontinuedonsickleaveaftertheycom‐pletedarehabilitationprogram(January‐June2007),whileStreibeltandcolleagues(50)in2012recruitedemployeeswhohadcompletedarehabilitationprogramandwereeligibleforPTSL.BothstudiesuseddatafromtheGermanPensionInsuranceAgency.Table4.Characteristicsofparticipants,interventionandcontrolgroupsinregistry‐basedstudies(n=12)Registry‐basedstudies

    Population Part‐timesickleave,PTSLN(%)

    Full‐timesickleave,FTSLN(%)

    Andrén2012(48)

    N=1170;SwedenAge:20‐64years(50%>46years)Diagnosis:MSDsGender:around60%femaleEthnicity:85%borninSweden

    N=140(12%) N=1030(88%)

  • 31 Results

    Andrén2014(28)

    N=627;SwedenAge:20‐64years(50%>46years)Diagnosis:MDsGender:around60%femaleEthnicity:85%borninSweden

    N=79(13%) N=548(87%)

    Bethge2016(17)

    N=3,750;GermanyAge:average45years(range18‐60)Diagnosis:Around63%MSDs.Otherdi‐agnoses:cardiac,oncological,psychoso‐maticGender:around50%femaleEthnicity:notreported

    N=1875(50%) N=1875(50%)

    Grødem2015(15)

    N=17,077;NorwayAge:>60years(bornafter1951)Diagnosis:MSDs(45.5%),MDs(25.4%)Gender:58%femaleEthnicity:notreported

    N=5294(31%)>50%PTSL(8.7%)

    50%PTSL(14.6%)

    50%PTSL,4.2%50%PTSL,2%

  • 32 Results

    Streibelt2017(50)

    N=762;GermanyAge:average47.8yearsDiagnosis:MDs(65%affectivedisorders)Gender:78%femaleEthnicity:notreported

    N=381(50%) N=381(50%)

    Viikari‐Juntura2017(51)

    N=3756;FinlandAge:20‐64(41%20‐44years,37%45‐54years,22%55‐64years)Diagnoses:MDsandMSDsGender:77.5%femalesEthnicity:notreported

    N=1878(50%) N=1878(50%)

    MSD=Musculoskeletaldisorder,MD=Mentaldisorder,SD=standarddeviationIntervention(partialsickleave=PTSL)

    Inthesectionbelow,wepresentthecharacteristicsoftheintervention,PTSL,intheRCTandRBsseparately.RandomizedcontrolledtrialIntheFinnishRCT(25;47),theGPsgavethepatientafitnote,indicatingthedurationofpartialworkdisability,whethercertainphysicalloadsshouldbereduced,andwhetheranyadditionalworkmodificationsweredeemednecessary.A50%PTSLwasgivento70%ofallsick‐listedemployees,whereasduetodifficultiesinarrangingahalfworkday,30%ofemployeesworkedshorterhourson3–4daysaweek.Sometaskmodifica‐tionswerealsoimplementedifnecessary.Registry‐basedstudiesInthe12RBs,alldataontheuseofPTSLweretakenfromthenationalregistriesintherespectivecountries(seeaboveNationalregistriesusedforanalysis).Themostcom‐monlyusedPTSLwas50%,whichwasgrantedinaround70%ofthegradedworkab‐sencesformostofthetime.ThestudyfromDenmarkdescribesPTSLasaworkplacein‐terventionprogramwhereby“sick‐listedworkersreturntotheirpre‐sickleavejobontemporarilyreducedworkinghours”(52).TheRBsanalyzeddataaboutsicknessab‐sences(bothPTSLandFTSL)grantedbetween2001and2014,whichgivesatimelineof13years.Figure2illustratesthedispersionoftheyearsfordataanalysisacrosstheRBs(i.e.,thetimelinefromwhichthedataweretakenintheregistry).ThetwoSwedishRBs,bothwithAndrénasfirstauthor,usedthesameyearsfromtheregistry,butin‐cludedworkerswithdifferentdisorders,MSDsandMDs,respectively(28;48).ItisimportanttohighlightthatallRBs,exceptfortwoNorwegianstudiespublishedbyGrødemandcolleagues(15)andNossenandBrage(44),exploredtheinfluenceofdif‐ferentcovariatesontherelationshipbetweenPTSLandtheoutcomemeasures.MostoftheRBsconductedpropensity‐scorematchinganalysesforbalancingthesamplesontheprobabilityofbeingassignedtoPTSL(sixstudies).ThemostcommoncovariatesusedacrosstheRBsweregender/sexandage(fivestudies),followedbytypeofoccu‐pationanddiagnosis(fourstudies),andgeographicarea,incomeanddataonthephysi‐cianwhograntedthesickleave(threestudies).Othercovariatesincludedthesickleaveduration,previoussickleaves,levelofeducation,etc.DetailsontheadjustedanalysesandthecorrespondingcovariatesacrossRBscanbefoundinAppendix4,anddefini‐tionsofthestatisticalanalysesarepresentedinAppendix5.

  • 33 Results

    Figure2.Dispersionoftheyearsfordataanalysisacrosstheregistry‐basedstudies(n=12)Comparison

    BoththeFinnishRCTandthe12RBsusedFTSLascomparator. Outcomemeasures

    Intotal,15outcomeswerereportedinthe13includedstudies.Therewerefourmaintypesofoutcomes:sicknessabsence,workparticipation,degreeofdisability,andhealth‐relatedoutcomes.Workparticipation(RTW)wasthemostcommonoutcome,reportedintenstudies(i.e.,intheRCTandnineRBs),followedbysicknessabsencedu‐ration,disability,disabilitypensionandallowanceofsocialbenefits(eachmeasuredbyfourstudies).Because12ofthe13includedstudieswereRBs,registrydatawerethemostcommonsourceofmeasurement.Table5showsthedifferentoutcomes,numbersofstudiesandtools.Table5.OutcomemeasuresandtoolsintheincludedstudiesOutcomemeasure Numberofstudies ToolsSicknessabsenceduration

    1RCT(25)3RBs(44;49;50)

    Registrydata

    WorkparticipationReturn‐to‐work(RTW)

    1RCT(25) Registrydata

  • 34 Results

    9RBs(1;15;28;43;48‐52)

    Unemployment 3RBs(49‐51) RegistrydataDegreeofdisabilityRecurrenceofsickleaveforanycause

    1RCT(25)

    Registrydata

    Disability 1RCT(47)3RBs(15;43;51)

    RegistrydataShirietal.2013(47)usedthefollowingtools:OswestryDisa‐bilityIndextoassessthedisabilitylevelduetobackpain;theNeckDisabilityIndextoassesscervicalspine‐relateddisabili‐ties;theQuickDASHtoassessthedisabilitiesofthearm,shoulder,andhand;andtheComprehensiveOsteoarthritisTest(COAT)toassessthesymptomsofthehiporknee.

    Productivityloss 1RCT(47) TwoquestionsrecommendedbyBrouweretal.,“Thesubjectswereaskedtoconsiderthelatestfullorpartialworkingdayandcompareittotheirnormalworkdaywhenansweringthequestions:(i)assesstheamountofworkyouwereabletoper‐form,and(ii)assessthequalityofyourwork.Forbothques‐tions,thescalerangedfrom0–10(0=verypoorto10=regularquantityorquality).Incasethereportedvaluewas

  • 35 Results

    Qualityappraisaloftheincludedstudies

    Whilenotarequiredstepinasystematicmappingreview,weassessedthemethodo‐logicalqualityofthe13includedstudies.WeuseddifferentchecklistsfortheRCTandthe12RBs(seemethods).RandomizedcontrolledtrialTheFinnishRCTexhibitedmoderatemethodologicalquality(25;47).Thereweresomeconcernsaboutbothperformanceanddetectionbiasduetothelackofblindingofbothparticipantsandoutcomeassessor.Inaddition,thetrialreportedsomeoutcomesthatwerenotpre‐specifiedintheprotocol.Wefoundnomajorconcernsforselectionorat‐tritionbias.SeeAppendix6foracompletedescriptionofthequalityappraisaloftheRCT.Registry‐basedstudiesWeusedachecklistfromtheNIPHhandbookforsystematicreviews(41)toassesstheoverallqualityoftheRBs,whichresultedinacategorizationofstudiesintolow,moder‐ateorhighmethodologicalquality,asfollows:

    Highquality:lowriskofbiasin≥8items. Moderatequality:lowriskofbiasin5‐7items. Lowquality:lowriskofbiasin≤4items.

    ElevenoutofthetwelveincludedRBsexhibitedmoderatemethodologicalquality(1;15;17;24;28;43;44;48;49;51;52).Oneshowedhighmethodologicalquality(50).Allstudiesincludedlargenumbersofindividuals,werejudgedasrepresentativeoftheirpopulation,andmeasuredbothexposureandoutcomesequallyandreliably.ThePTSLandFTSLgroupswerecomparableonimportantbackgroundfactorsinfivestudies(1;15;28;50;51).Follow‐uptimewasjudgedasadequateinallstudies.SeeAppendix7foracompletedescriptionofthemethodologicalappraisaloftheRBs.Summaryofmainfindingsfromtheincludedstudies

    Weprovideabriefsummaryofthemainfindingsreportedbythestudyauthorsfortheoutcomesincludedinthisreview,i.e.,sicknessabsence,workparticipation,degreeofdisabilityandrehabilitationbenefits,andhealth‐relatedoutcomes.Furtherdatacanberetrievedinthefull‐textpublications.Asummarytable,indicatingdirectionofresultsacrossthestudies,isprovidedattheendofthechapter(table6).Sicknessabsenceduration

    TheFinnishRCTofmoderatemethodologicalquality,andthreeRBs,ofmoderateandhighmethodologicalquality,reportedonsicknessabsence.TheFinnishtrialshowedalowerproportionofsicknessabsencedaysinemployeeswithPTSLthaninpeerswithFTSLthroughoutthe12‐monthfollow‐upperiod(20%loweronaverage)(25).

  • 36 Results

    ThreeRBsmeasuredsicknessabsenceduration.TheNorwegianRBpublishedbyMarkussenandcolleagues(49)foundthatPTSLpredictedreductionsinsicknessab‐sencedurationbymorethan60daysaftercontrollingforpatient/jobcovariatesandphysiciancharacteristics,comparedtoFTSL.Thisreductionincreasedupto74dayswhenspellsexceeding12weekswereanalyzed.AnotherNorwegianstudy,byNossenandBrage(44),observedthattheuseofPTSLinspellslastingatleast15daysandthatwereonFTSLduringthefirst14daysledtoa21daysshortersicknessabsencedura‐tioncomparedtotheuseofFTSL.LargerreductionsinfavorofPTSLwereseenafter8weeksinspellslastinglongerthan2weeksandgradedduringthefirst2weeks(166daysinPTSLvs199daysinFTSL;meandifference=‐33days).ThisdifferenceinfavorofPTSLincreasedupto39daysat12weeks.Conversely,crudeanalysesrevealedshortersicknessabsencesamongthoseassignedtoFTSLcomparedtothoseinPTSL(115daysinPTSLvs23daysinFTSL;meandifference=92days).Thisdifferencewasreducedto13dayswhendataforspellsgradedafter2weekswereanalyzed1.Theanal‐ysisofspellsgradedat

  • 37 Results

    morethanoneandahalftimesaslikelytoRTWthanthoseonFTSL.Controllingforprevioussicknessabsenceduringthepreceding30daysdecreasedtheHRby11%andcontrollingforbodymassindexdecreaseditby3%.OverallHRforRTW,controllingforage,paininterferencewithsleep,andprevioussicknessabsence,was1.76(95%CI1.21–2.56).ThreeoftheNorwegianRBsreportedonworkparticipation.Grødemandcolleagues(15)reportedthatemployeesonPTSLstayedconnectedtotheirjobsmorethantheirpeersonFTSLattwoyearsafterterminationofthesicknessbenefits(38%inFTSLvs84%in

  • 38 Results

    sociatedwithagreaterlikelihoodoffullrecoverycomparedtoFTSL(averagetreat‐menteffect0.015)2whenitisassignedinthebeginningofthespell.Andrénalsoob‐servedastrongpositiveeffectofPTSL(averagetreatmenteffect0.387)2,andstatisti‐callysignificant,whenassignedafter60daysofFTSLattheendofthe330daysobser‐vationperiod.DistributionalanalysisoftheeffectparametersshowedthatinagroupofrandomlyselectedemployeesonsickleaveformorethantwoweeksduetoaMD,17.8%ofthemwouldfullyrecovertheirlostworkcapacityifassignedtoPTSLinthebeginningofthespell,butwouldnothavefullyrecoveredtheirlostworkcapacitywith‐outthePTSLtreatment.However,16.3%ofthemwouldnotfullyrecoverifassignedtoPTSL.TheotherthreeRBsthatreportedonworkparticipationwerefromFinland(twostud‐ies)andGermany.InFinland,Kaustoandcolleagues(1)observedreductionsinthelevelofworkparticipationforboththePTSLandtheFTSLgroupsduringtheone‐yearfollow‐up,theabsolutereductionbeinglargerintheFTSLgroup(−26.5%)ascomparedwiththePTSLgroup(−21.2%),whichmeansadifferenceof5.3%(95%CI3.1%to7.5%).Thisdifferenceincreasedupto9.8%(95%CI5.9%to13.7%)inthepropensityscorematchedsubsample(i.e.,theconditionalprobabilityofbeingassignedtoPTSLgivenobservedcovariates).Subgroupanalysesshowedthatinallagecategories,workparticipationdeclinedmoreintheFTSLgroupthaninthePTSLgroup.Thedifferenceinthedeclinewassignificantinagecategories45–54and55–65.Therewasnoeffectinthoseaged35–44.Insubgroupanalyses,astatisticallysignificantlylargereffectinfa‐vorofPTSLwasfoundforpeoplewithmentaldisordersascomparedwiththeotherdi‐agnosticcategories(difference12.8%,95%CI9.0%to16.5%).AnotherFinnishstudypublishedin2017byViikari‐Junturaandcolleagues(51)foundanabsoluteriskdifferenceof8.0%andarelativeriskdifferenceof10.9%infavorofPTSLonsustainedRTW.Inaddition,theauthorsobservedthatthemeanoveralltimespentatworkwas77.4%;itwas10.5%higherinthePTSLgroupcomparedtotheFTSLgroupduringthe2‐yearfollow‐up.SubgroupanalysesshowedthatthedifferencewaslargeramongmenthanwomenandforpeoplewithMDscomparedtoMSDs.InGer‐many,theRBofhighmethodologicalquality,byStreibelt(50),foundthat88.4%ofthePTSLgrouphadreturnedtoworkat15monthsfollow‐upcomparedtoonly72.6%ofthecontrols(RelativeRisk[RR]=1.22,95%CI1.13–1.31).TherelativeriskofreturningtoworkwasgreaterinthePTSLgroupcomparedtoFTSL.ThegreatesteffectofPTSLonRTWwasobservedamongemployeeswhodidnotbelievethattheywouldgobacktoworkafterrehabilitation(74%inPTSLvs49%inFTSL).UnemploymentThreeRBsreportedonunemployment.InNorway,Markussenandcolleagues(49)ob‐servedthatPTSLpredictedariseintheemploymentprobabilitytwoyearsafterthestartofthesickleavebyaround16%(SemiparametricLeastSquares(SLS)estimate0.16,standarderror0.04),aftercontrollingforpatient/jobcovariatesandphysiciancharacteristics.Thisprobabilityincreasedupto20%whenspellsexceeding12weekswereanalyzed.InGermany,Streibelt(50)foundthatsick‐listedemployeesassignedtoPTSLhada60%lowerriskofunemploymentcomparedtopeerswhowereassignedto

  • 39 Results

    FTSL(RR0.41,95%CI0.26to0.65).Finally,TheFinnishRBpublishedbyViikari‐Jun‐turaandcolleagues(51)observedthatsick‐listedemployeeswhoreceivedPTSLspentlesstimeunemployedduringthe2‐yearfollow‐upcomparedtothosewhoreceivedFTSL.Thedifferenceinproportionswasabout1.8‐fold(3.2%inFTSLvs1.8%inPTSL).Thisdifferencewaslargeramongmenthanwomenandinworkersinmanufacturingcomparedtootherindustries.Insummary,oneRCTfromFinlandandallofthenineRBsthatmeasuredRTW,excepttheNorwegianRBbyLie(43),indicatedpositiveeffectsonRTWforemployeesonPTSLcomparedtoFTSL(15;49‐51).FavorableeffectsofPTSLcomparedtoFTSLonunem‐ploymentwerereportedbyallofthethreeRBsthatmeasuredthisoutcome(49‐51).Degreeofdisabilityandrehabilitationbenefits

    Therewerefivetypesofoutcomeswithregardtodegreeofdisabilityandrehabilitationbenefits:recurrenceofsickleaveforanycause,disability,productivityloss,disabilitypension,andallowanceofsocialwelfarebenefits.Wereportthestudyresultsforeachofthesefiveoutcomesseparatelybelow.RecurrenceofsickleaveforanycauseTheFinnishRCT(moderatemethodologicalquality)(25)indicatedthattimetofirstre‐currentsickleavewassimilarinthePTSLandFTSLgroups.However,thenumberofrecurrentsickleavesperpersonyearaftertheinitialsicknessabsenceperiodwasabout20%lowerinthePTSLgroupatone‐yearfollow‐up.DisabilityTheFinnishRCTandthreeRBsreportedondisability.Allhadmoderatemethodologicalquality.NodifferencesbetweenPTSLandFTSLregardingdisabilitywerereportedbytheFinnishRCTatone‐yearfollow‐up(47).ThethreeRBsreportingondisabilitywerefromNorway(twostudies)andFinland.Us‐ingNorwegiandata,Lie(43)foundnostatisticallysignificantdifferencesbetweenPTSLandFTSLonemployees’disabilityaftercontrollingforcovariates(i.e.,age,sex,diagno‐sis,timeinjob,andphysiciandata).Grødemandcolleagues(15)observedthelargestrecoveryamongemployeeswhohad

  • 40 Results

    4.5‐foldcomparedtotheFTSLgroup(7.9%versus1.8%);theoverallabsoluteriskdif‐ferencewas‐6.1%(95%CI‐7.1to‐4.9)(negativevalueindicatingincreaseinrisk).Higherriskswereseenamongwomen,theoldestemployees,andpeoplewithMSDscomparedwithMDs,andamongpeopleinthepublicsectorandhealthcareandsocialwork.Theseresultsremainedevenafteradjustingforresidualimbalanceinbaselinecovariates(e.g.,age,majorregion,employmentsector,socioeconomicstatus,andan‐nualgrossincome).Insum,oneRCTfromFinland(47)andoneRBfromNorway(43)foundnodifferencesbetweenPTSLandFTSLondisability,whereastwoNordicRBssuggestedpositiveef‐fectsofPTSLonemployees’disability(15;51),exceptwithregardtopartialdisabilityretirementintheFinnishRB(51).ProductivitylossOnlytheFinnishRCTreportedonproductivityloss.DatafromthisRCTofmoderatemethodologicalqualityfoundtherewerenosignificantdifferenceonproductivitylossbetweenPTSLandFTSLuptoone‐yearfollow‐up(regressioncoefficient‐0.6;95%CI‐9.1to7.9;p‐value=0.88).However,thiseffectbecamefavorableforPTSLafteradjust‐ingforbodymassindex,follow‐uptime,timesincebeginningofsymptoms(numberofelapseddays)andthebaselinemeasurebutdidnotreachstatisticalsignificance(re‐gressioncoefficient2.3;95%CI‐4.8to9.5;p‐value=0.52)(47).DisabilitypensionFourRBs,fromNorway,Finland,andGermany(twostudies),reportedondisabilitypension.ThreeoftheRBshadmoderatemethodologicalqualityandonehadhighmethodologicalquality.InNorway,Grødemandcolleagues(15)reportedthatthehigh‐estrateofreceivingdisabilitypensionwasobservedinemployeeswhowereon50%PTSL(12%attheterminationofsicknessbenefits,and19%twoyearslater),whereastheratevariedfrom7%upto13%attheendoftheobservationperiod(January2014)amongemployeeswhowereonFTSL.Thelowestlikelihoodofreceivingadisabilitypensionwasseeninthegroupof

  • 41 Results

    MDsthaninMSDs.NoassociationswereobservedbetweenPTSLandthetransitiontoanydisabilitypension(partialandfulldisabilitypensioncombined).Lastly,twoGermanRBsexamineddisabilitypension.Bethgeandcolleagues(17)re‐portedthatassigningPTSLtosick‐listedemployeesreducedtheirriskofreceivingadisabilitypensionby40%(HR=0.62,95%CI0.49–0.80)atone‐yearfollow‐up.Streibeltandcolleagues(50)reportedthatPTSLreducedtheriskofreceivingadisabilitypen‐sionby60%(RR=0.40,95%CI0.23‐0.70)comparedtoFTSLat15monthsfollow‐up.Thisstudyhadhighmethodologicalquality.Insum,acrossthefourRBs,theresultsfordisabilitypensionweremixed.TheNorwe‐gianRBsuggestedahigherrateofreceivingdisabilitypensionamongemployeesonPTSLcomparedtoFTSL(15),whereasthetwoGermanRBsreportedadecreasedriskofreceivingadisabilitypensioninemployeesonPTSL(17;50).TheFinnishstudy(24)foundthatPTSLreducedtheriskoffulldisabilitypensioncomparedtoFTSL,whereastheoppositeresultwasfoundforpartialdisabilitypension.AllowanceofsocialwelfarebenefitsFourRBs,fromNorway(threestudies)andGermany,reportedonallowanceofsocialwelfarebenefits.AllfouroftheseRBshadmoderatemethodologicalquality.InaNorwegiansetting,Markussenandcolleagues(49)foundthatPTSLwasassociatedwithfewersocialsecurityclaims(regressioncoefficientadjustedforpatient/jobco‐variatesandphysiciancharacteristics:‐79.7(standarderror11.8))inthe2‐yearperiodfollowingjustaftertheendoftheabsencespell.Thisreductionincreasedupto99daysreceivingbenefitswhenspellsexceeding12weekswereanalyzed.Lie(43)foundthattheprobabilityofreceivingsocialbenefitswasloweramongthoseonPTSLthanFTSL,althoughthedifferencesweresmallandnon‐significant(HRrangedfrom0.95at4weeksto0.80at28weeks)aftercontrollingforcovariates(i.e.,age,sex,diagnosis,timeinjob,anddoctor’sdata).Thesequentialanalysisdidnotrevealdifferencesbetweensecondandthirdsickleaves.Grødemandcolleagues(15)reportedthatallgroups,butnot50%(69%attermination,and40%twoyearsafter),and50%PTSL(59%attermination,and30%twoyearsafter).Theallowanceofsocialbenefitsremainedstableat10%inthe50%PTSL.TheGermanstudy,byBethgeandcolleagues(17),reportedthatemployeeswithPTSLreceivedfewerwelfarebenefitsduetosicknessabsenceandunemploymentuptotheendofthestudyperiodthanthoseinFTSL.Theaccumulatedtimeofreceivingsicknessbenefitswasreducedby52days(95%CI40–64days),short‐termunemploymentben‐efitsby58days(95%CI49–67days),andlong‐termunemploymentbenefitsby15days(95%CI10–20days)atone‐yearfollow‐up.

  • 42 Results

    Thus,allfourRBs(15;17;43;49)observedalowerallowanceofsocialwelfarebenefitsinPTSLcomparedtoFTSL.Health‐relatedoutcomes

    Onlytwooftheincludedstudiesreportedonhealth‐relatedoutcomes.ThiswastheFinnishRCT(25;47)andaGermanRB(50).TheRCThadmoderatemethodologicalqualityandtheRBhighmethodologicalquality.TheFinnishRCTincludedpeoplewithMSDswhiletheGermanstudyincludedpeoplewithMDs,primarilyaffectivedisorders.Below,wereporttheresultsforthesixhealth‐relatedoutcomesseparately.Thesewere:pain,self‐ratedgeneralhealthandhealth‐relatedqualityoflife,physicalandemotionalfunctioning,depression,anxiety,andworkingability.Pain(intensityandinterferencewithwork)ResultsfromtheFinnishRCT(47)showedreductionsinbothpainintensityandinter‐ferencewithworkinallgroupsduringthefirst8weeksandstabilizedthereafter.NodifferencesbetweenthePTSLandFTSLgroupswereobservedduringa12weeksfol‐low‐upperiodafteradjustingforbodymassindex,follow‐uptime,timesincebeginningofsymptoms(numberofelapseddays)andthebaselinemeasure.Thus,painintensity(≤3months)showedaregressioncoefficientof‐0.4(95%CI‐1.3to0.4;p=0.31);paininterferencewithwork(≤3months)‐0.7(95%CI‐1.6to0.3;p=0.15);paininterferencewithsleep(≤3months)‐0.12(95%CI‐0.9to0.7;p=0.77),andpainat1year‐0.2(95%CI‐0.7to0.4;p=0.48).Self‐ratedgeneralhealthandhealth‐relatedqualityoflifeTheFinnishtrial(47)foundthatemployeeswhoreceivedPTSLself‐reportedbettergeneralhealththanthoseintheFTSLgroup(regressioncoefficient0.5,95%CI‐0.0to1.0;p=0.07),andhigherhealth‐relatedqualityoflifeatone‐yearfollow‐up(regressioncoefficient‐0.5,95%CI‐0.9to‐0.01;p=0.02).Theseanalyseswereadjustedforbodymassindex,follow‐uptime,timesincebeginningofsymptoms(numberofelapseddays)andthebaselinemeasureoftheoutcome.PhysicalandemotionalfunctioningStreibeltandcolleagues’(50)resultsinGermanyshowedthatemployeeswhoreceivedPTSLhadahigherphysical(regressioncoefficient+7.9,p=0.01)andemotional(regres‐sioncoefficient+6.8,p=0.025)rolefunctioncomparedtothoseintheFTSLgroupat15monthsfollow‐up.DepressionNodifferenceswereobservedintheFinnishRCTbetweenthePTSLandFTSLgroupsonsick‐listedemployees’depressionsymptoms(47).Conversely,intheGermanRB(50),peopleinthePTSLgroupdidbetterthanpeopleintheFTSLgroup(regressionco‐efficient−0.6,95%CI−1.1to−0.1;p‐value=0.03)at15monthsfollow‐up.AnxietyDatafromtheGermanRB(50)showedthatpeopleinthePTSLgroupimprovedwithrespecttoanxietysymptoms(measuredwiththesametoolasdepression),compared

  • 43 Results

    toFTSL(regressioncoefficient−0.6,95%CI−1.1to−0.1;p‐value=0.03)at15monthsfollow‐up.WorkingabilityTheGermanRB(50)foundthatpeopleinthePTSLgroupdidbetterthanpeopleintheFTSLgroupwithrespecttoworkingability(regressioncoefficient0.1,95%CI‐0.1to0.3;p=0.05)at15monthsfollow‐up,butthedifferencewasnotstatisticallysignificant.Summaryofresultsacrosstheincludedstudies

    Table6summarizesthedirectionofresultsacrossthe13includedstudies(15out‐comes).Withregardtocausaleffects,theRCTpresentsthestrongeststudydesignandisthereforehighlighted.However,giventhestudy’ssmallsamplesize(n=62)firmcon‐clusionsabouttheeffectsofPTSLcannotbedrawn.

  • 44 Results

    Table6.Summaryofdirectionofresultsacrosstheincludedstudies(n=13)

    Legend:+favorstheintervention(partialsickleave,PTSL);‐favorsthecontrolgroup(full‐timesickleave,FTSL);=nodifferencebetweenPTSLandFTSL;*Randomized‐controlledtrial(RCT);#studyofhighmethodologicalquality,remainingstudieshadmoderatemethodologicalquality.Emptycellmeansthestudydidnotexaminetheoutcome.

    Outcomemeasure

    André

    n2012(4

    8)

    André

    n2014(

    28)

    Bethg

    e2016 (1

    7)

    Grødem

    2015 (15

    )

    Høgel

    und2

    010 (

    52)

    Kaust

    o2012 (2

    4)

    Kaust

    o2014 (1

    )

    Lie20

    14 (43

    )

    Marku

    ssen2

    012 (4

    9)

    Nosse

    n2013 (

    44)

    Shiri2013(47)*

    Viikari‐Juntura2012(25)*

    Streib

    elt20

    17 (50

    )#

    Viikari‐Jun

    tura2

    017 (

    51)

    Sicknessabsence + + + + WorkparticipationReturn‐to‐work + + + + + ‐ + + + +Unemployment + + +DegreeofdisabilityandrehabilitationbenefitsRecurrenceofsickleaveforanycause = Disability + = = +Productivityloss = Disabilitypension + ‐ + + Allowanceofsocialwelfarebenefits + + + + Health‐relatedoutcomesPain(intensityandinterferencewithwork)

    = Self‐ratedgeneralhealth + Health‐relatedqualityoflife + Physicalandemotionalfunctioning

    + Depression = + Anxiety + Workingability +

  • 45 Discussion

    Discussion

    Mainfindings

    Todate,12RBs(fromtheNordiccountriesandGermany)andoneRCTfromFinlandhaveinvestigatedtheeffectsofPTSLcomparedtoFTSLinmorethan2.74millionsick‐listedemployees.Allstudieshadmoderatemethodologicalquality,exceptoneRBs,whichhadhighmethodologicalquality.Thisindicatesconsistenthighinternalvalidityintheresearchmethodsused,butitisimportanttostressthatRBshavelimitedcapac‐itytodetectcausaleffects.TheFinnishRCTstudiedemployeeswhoweresick‐listedduetoMSDs,whiletheRBsincludedemployeeswithprimarilyeitherMSDsorMDs.Whilefirmconclusionscannotbedrawn,theRCTandtheRBssuggestedPTSLmaybeassociatedwithshortersicknessabsenceandhigherworkparticipation.TheFinnishRCTreportedthatemployeeswithPTSLexperiencedbettergeneralhealthandqualityoflifecomparedtothoseonFTSL.However,itdidnotfindstatisticaldifferencesbe‐tweenPTSLandFTSLonsickleaverecurrence,employees’productivityloss,andpain.TheRBsindicatedalowerprobabilityforpeopleonPTSLofreceivingbothdisabilitypensionandallowancebenefits,disability,aswellasbetterscoresonphysical‐andemotionalfunctioning,anxiety,depression,andworkingability.TheresultsregardingsicknessabsenceandworkparticipationaresupportedbyaNor‐wegianRB(26),whichusedthesameNAVdatasetasLie(43)andpartiallyMarkussenandcolleagues(49),bothincludedinthisreview.Kannandcolleagues(26)demon‐stratedthatanincreaseintherateofuseofPTSLinamunicipalityofonepercentagepoint(e.g.from13%to14%)wasassociatedwithareductioninthesicknessabsencerateof1.79%,andshortersicknessabsenceduration.Thatis,whentheproportionofdaysofsickleavethatweregradedincreasedbyonepercentagepoint,therateofsick‐nessabsencedecreasedbyabouttwopercent.Thus,theresearchersconcludedthatgreateruseofPTSLcaninsubsequentmonthsleadtoareductioninthesicknessab‐sencerate,durationofsicknessabsence,andnumberofindividualsonsickleave.Asimilaranalysiswithdatafrom2000to2011reachedthesameconclusions,althoughtheassociationsinthisanalysiswereweaker(46).Oursystematicmappingreviewidentifiedsomegapswithregardtothedifferentout‐comesmeasuredacrossstudies.Workparticipationwasthemostcommonoutcomere‐ported,measuredintenstudies,followedbysicknessabsenceduration,disability,disa‐bilitypensionandallowanceofsocialwelfarebenefits,withfourstudieseach.Incon‐trast,therecurrenceofsickleavewasonlymeasuredinonestudy(theRCT).Therewas

  • 46 Discussion

    animportantlackofknowledgeregardingtheeffectofPTSLforhealth‐relatedout‐comes,asonlytwostudiesaddressedthisissue(table6).Further,itshouldbenotedthattheoverwhelmingmajorityofthestudypopulationswereadultssufferingfrommusculoskeletal‐ormentaldisorders.Noneofthestudiesspecificallyincludedpeopleonsickleaveforotherreasons.ItispossiblethateffectsofPTSLarerelatedtodiagno‐sis.Forexample,Høgelundandcolleagues(29),whocombinedsurveyandregisterdataonabout850Danishworkers,foundthatPTSLhadnoeffectonthedurationuntilre‐turningtoregularworkinghoursforemployeeswithMDs,butsignificantlyreducedthedurationuntilreturningtoregularworkinghoursforemployeeswithotherdisorders.Generalizabilityandstrengthoffindings

    TheOECDhasreportedthattheinsufficientlaborforceparticipationamongpeoplewithhealthissuesanddisability,theirlowincome,andthehighcostsofsicknessanddisabilitybenefitschemesrepresentaseriousproblemforgovernments,andtheuseofPTSLmightbeasuitablemeasuretocounteractthem(2).Animportantpointinfavorofthegeneralizabilityofthefavorablefindingsfromthestudiesincludedinthissys‐tematicmappingreviewisthepredominanceofNordicstudies.Elevenofthe13studieswerefromaNordiccountry,includingfourfromNorway.Further,aconsiderablegroupofemployeesintheincludedstudiesweresick‐listedduetoMSDsandMDs.TheformerrepresentsthemainoccupationaldiseasessufferedbyEuropeanworkers,accordingtotheEuropeanObservatoryofWorkingLife(55).InNorway,MSDsareamongthemostcommonreasonsforconsultationtoGPsandemergencyprimaryhealthcare,andrep‐resentthemajorityofdaytreatmentsinthenationalhealthsystem(56).Moreover,withregardtoMDs,datafromtheSwedishSocialSecurityAgencyshowthatMDsac‐countedforaroundhalfofallsickleavecasesamongwomenand40%ofallcasesamongmeninDecember2016.In2016,PTSLrepresentedaround30%ofallsickleavecasesandwasespeciallyhighamongpeoplewithMDs(14).AllRBsuseddatafromstructurednationwideregistries.TheNorwegianstudiesuseddatafromNAV,whichmightfacilitatetheformulationofpublicpoliciesandfurtherre‐searchoftheuseofPTSLforcontrollingsicknessabsence.WenotethatthetwoGer‐manstudiesconcernedatotalofabout4500employees–andthereforecontributeslesstotheoverallfindings–whocompletedarehabilitationprogram,whichismanda‐toryinGermany,butnotstandardpracticeinNorwaywherepeoplegenerallystartPTSLearlyinthecourseofthesicknessabsence.InGermany,PTSLisgrantedwhenthesick‐listedemployeehascompletedtherehabilitationprogrambutisstillunabletoperformfullduties,anditisapprovedbytherehabilitationphysicianandthesocialworkerwithconsentfromtheemployer,thepatient,thegeneralpractitionerandtheoccupationalphysician(57‐59).Aspartoftheschemedevelopedbytherehabilitationphysician,thesick‐listedemployeestartsworkingforatleasttwohours/dayandgrad‐uallyincreasestheworkingtime(58;59).

  • 47 Discussion

    Strengthofevidence

    Thetwotypesofstudydesignsandresearchapproachesthatrepresentthebodyofevi‐denceontheeffectsofPTSLversusFTSLmeritsomediscussionintermsofthepossi‐bilitytodrawcausalinferencesfromtheirfindings.TheFinnishRCTrepresentsthestrongeststudydesigntoanswertheresearchquestionthatguidedthissystematicmappingreview,asitiswidelyacceptedthatwell‐conductedprospective,experimentalstudieshavethegreatestcapacitytodetectcausaleffectsduetotheirpossibilitytoran‐domlyassignindividualstodifferentexposures,andthereforeensurethatgroupsaresimilar(60).Essentialsupportforthisstatementmaybebasedonthecounterfactualapproachforevaluatingcausalinferenceinepidemiology,whicharguesthatahighcomparabilitybetweenexposedandunexposedindividualsisneededtoestimateanycausaleffect,asitisnotpossibletoobserveanindividual’soutcomebothatthetimewhenheisexposedandatthesametimewhenheisnot(61‐63).Nevertheless,randomassignmentisnotsufficienttoensurehighvalidityofexperimentalstudies,asalsothesemayhavelimitationsthatcanleadtobiasedestimatesofcausaleffects(e.g.,lowadherencetotheintervention,highattrition,andoutcomemeasurementerrors)(40‐42;64;65).Additionally,ethicalconstraintsforconductingexperimentalresearchareacommonconcernthatturnsthefocustoobservationaldata.Inspiteofthepreferenceforexperimentalstudieswhenaddressingquestionsabouteffect,andasnoticedinourfindings,thebodyofevidenceaboutthebenefits/draw‐backsofPTSLcomparedtoFTSLismostlyrepresentedbyRBsthatuseobservationaldataderivedfromnationwideregistries.Whileabroaddiscussionaboutcausalinfer‐encegoesbeyondthescopeofthissystematicmappingreview,weofferafewnotesaboutthecapacitytodrawcausalinferencesfromobservationaldata.Observationalstudiesestimatedifferencesonacertainoutcome“X”amongindividualswithdifferentlevelsofanexposure“Y”(63;66),andnumerousmethodologicalapproachesarede‐scribedintheliteraturetoestimatecausaleffectsbasedontheirdata(62;63;66).Someofthemajorconstraintstodetectcausalinferencesinobservationaldataaretiedtothesusceptibilityofselectionbiasduetoanon‐randomdistributionoftheexposure,thepossibilityofconfounding,reversecausation,andtheoptiontoseeoutcomedatabe‐foretheallocationoftheindividualstothegroupsofstudy(62;67).Outcomedataanal‐ysisisnotprecededbytheallocationoftheindividualstodifferentexposurelevels,thusanequaldistributionofcovariatesbetweenexposedandunexposedindividualsmaynotbeensured(66;6